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Aminopiperidine based complexes for lactide polymerisation 
P. McKeown,a,b M. G. Davidson,a,b J. P. Lowe,b M. F. Mahon,c,* L. H. Thomas,b T. J. Woodman,a and 
M. D. Jonesb,* 
Herein we report the synthesis and characterisation of a series of salalen and salan ligands derived from 2-
(aminomethyl)piperidine. Depending on the choice of starting salicylaldehyde, a bicyclic salan type ligand (1-3H2) or imino 
salalen type ligand (4-6H, 7-9H2) were prepared. The ligands were successfully complexed to group 4 metals and aluminium; 
with hafnium and zirconium octahedral complexes, M(1-3)2, were realized; whilst with aluminium tetrahedral and trigonal 
bipyramidal complexes, Al(1-9)Mex (x = 1,2), were isolated. The complexes have been characterised in solution via 1H and 
13C{1H} NMR spectroscopy and in the solid state by X-ray crystallography. The group 4 complexes were observed to have a 
fac-fac arrangement of ligands and there were two isomers present when 3H2 was ligated. The imino aluminium complexes 
Al(7-9)Me were isolated as a mixture of diastereoisomers. The resultant complexes were trialed in the ring opening 
polymerisation of rac-lactide with both heterotactic and isotactic PLA being demonstrated. Tacticity was found to be 
dependent on the nature of the ligand and metal used; the M(1-3)2 complexes were generally found to have a heterotactic 
preference (Pr = 0.67-0.76) and the aluminium polymerisation outcome was dictated more by the steric influence of the 
ligand, particularly for Al(4-6)Me2/Al(7-9)Me. 
Introduction 
Sustainable plastics are receiving increased interest due to 
dwindling petrochemical resources and a desire for more 
biodegradable materials. At the forefront of such research are 
polylactic acid (PLA) based materials, which can have similar 
properties to petrochemical derived polymers and a broad 
range of applications.1 There are a range of polymer 
microstructures that can be accessed and this can be tuned by 
varying the stereochemistry of the monomer and judicious 
choice of initiator; in particular, there is great emphasis placed 
on controlling the chain stereoregularity in the polymerisation 
of rac-lactide (rac-LA) to achieve improved polymer properties.2 
For this, an initiator capable of polymerizing rac-LA with strong 
isoselectivity and fast kinetics is urgently being sought.3 This is 
related to the desired properties (higher Tm) of the resulting 
polymer. There are a range of initiators in the literature with 
metals such as Sn(II)4, Zn(II)5, Al(III)2g,6, In(III)7, Group II5b,8, rare-
earth3,9 and Group IV6a,10 being widely reported. 
Common themes previously seen in successful ring opening 
initiators for lactide polymerisation include a cyclic backbone 
and a stereocentre, allowing for enantiomorphic control over 
the propagating chain.2b,2g,5a,5e,6b,6g,6j,7a,7e,10c,11 The metal centre 
employed can also have a profound effect on the 
polymerisation outcome.6a,9b Early work by Spassky and co-
workers demonstrated this approach by using R-
binapthyldiamine ligands with an Al(III) centre.2g,6j These salen 
complexes showed a distinct preference for the polymerisation 
of D-lactide leading to isotactic stereocomplexed PLA. Feijen et 
al have utilized Jacobsen’s ligand containing a trans-1,2-
diaminocyclohexyl backbone for rac-LA polymerisation.6g,11c 
Once again, aluminium was used and isotactic PLA was realized 
on application of the racemic complex. A series of 
unsymmetrical Al(III) salalens based around this 
diaminocyclohexyl structure were prepared by Jones et al.6b 
Moderate stereocontrol was observed for all complexes with 
greatest heterotacticity being related to chloro-substituted 
phenyl moieties. More recently, work by Kol has demonstrated 
the use of chiral aminomethylpyrrolidine salalen ligands with 
aluminium giving heterotactic or gradient isotactic PLA 
depending on aryl substituents.6c  
Chiral bipyrrolidine based complexes feature in recent 
investigations by Jones et al.6a,10c These reports highlight the use 
of Zr(IV) and Hf(IV) initiators to afford PLA exhibiting moderate 
isotactic bias in the melt, although Pm values up to 0.86 can be 
achieved in solution. Interestingly, replacing the group 4 metal 
with Al(III) caused a shift in selectivity towards heterotactic 
PLA.6a Other metals have also been demonstrated for the ROP 
of lactide. Abbina and Du have recently described a novel 
amido-oxazolinate ligand as a tuneable alternate to the β-
diketiminate motif.5a The corresponding chiral zinc complexes 
were shown to polymerise rac-lactide with both a fast rate and 
strong isotactic preference with evidence of 
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stereocomplexation. Mehrkhodavandi et al. have reported a 
series of dinuclear In(III) initiators involving chiral, cyclic 
backbones.7a,7e In the first instance enantiomerically pure 
[(NNO)InI(µ-OEt)]2 complexes were prepared and applied to the 
room temperature polymerisation of lactide. The highest 
stereocontrol was achieved using a tBu/Me substituted aryl ring 
with slight isotactic preference being reported. Further work 
saw the employment of Jacobsen ligand to yield 
[(ONNO)InOEt]2 complexes. In solution, high activity is observed 
as well as a more pronounced isotactic bias. The analogous 
phosphasalen incorporating a cyclohexyl backbone has been 
reported by Williams et al.9a These yttrium alkoxide based 
initiators demonstrated high activity towards rac-LA 
polymerisation and induced a strong heterotactic bias in the 
resulting PLA. 
In this paper, the synthesis of salalen and salan type ligands 
based on a 2-(aminomethyl)piperidine backbone is reported 
and discussed. These have been complexed to a range of metals 
{Al(III), Zr(IV), Hf(IV) and Ti(IV)} and trialed for the ring opening 
polymerisation of rac-LA. 
Results and discussion 
The condensation between 2-(aminomethyl)-piperidine and 
various 3,5-substituted salicylaldehydes yielded two distinct 
products; for salicylaldehydes bearing alkyl moieties the 
expected imine product was formed as the major species. 
However, for the 3,5-di-halosalicyaldehyde starting materials 
the imine appears as the minor species with a bicyclic tautomer 
being the major isolated product. Such compounds have been 
previously been prepared by Beim and Day who also observed 
a dynamic equilibrium between the two tautomeric forms.12 
However, herein is the first systematic synthesis and application 
of these bicyclic species in catalysis. 
For these sets of precursor ligands, the distribution of products 
can be related to the electron donation of the substituents of 
the aryl group; inductive donors such as tBu, Me and Ad 
disfavour the cyclization due to increased electron density on 
the benzyl carbon. Conversely, electron withdrawing halo 
groups facilitate intramolecular attack. As in the work of Beim 
and Day, interchange between the cyclic and acyclic structures 
is observed via variable temperature (VT)-NMR spectroscopy.12 
This chemical exchange is further shown through EXSY NMR in 
which there are clear cross peaks between the two forms (see 
ESI, Figure SI2) 
The corresponding bisphenol ligands were realized by an SN2 
reaction with 3,5-di-tert-butyl-2-hydroxybenyzlbromide 
affording the salalen or salan moiety depending on the on the 
aryl substituents (Scheme 1). Characterisation of all ligands, 1-
9Hx (x = 1,2), included 1H/13C{1H} NMR spectroscopy, high 
resolution ESI-MS and the bicyclic salan structure of 1H2 was 
further characterised by X-ray crystallography (see ESI, Figure 
SI5). Ligands based on this fused ring system are rare and this is 
the first reported synthesis of a phenolate version of such a 2-
azaindolizidine ring system and its use in catalysis. The bicyclic 
systems offer an interesting motif in which the rigid backbone 
confers a tighter tridentate coordination as the bridging 
nitrogen does not participate in bonding to the metal centre. 
This is contrasted by the tetradentate imine form in which both 
nitrogen atoms are well positioned to contribute to metal 
coordination. 
The zirconium (IV), hafnium (IV) and aluminium (III) complexes 
were formed and characterised via single crystal X-ray 
diffraction (where appropriate), solution-state NMR 
spectroscopy and elemental analysis. 
Reaction of the tridentate ligands 1-3H2 with zirconium 
exhibited a strong preference for the coordination of two 
ligands around one metal centre yielding a 6-coordinate 
species. In the solid state these bis-ligated zirconium 
complexes, Zr(1-3)2, show a pseudo octahedral Zr(IV) centre 
with fac-fac binding of the two ligand sets. For the chloro- and 
bromo- complexes, Zr(1/2)2, the ligands bind to the metal 
centre so that the halophenoxy groups approach in a trans 
configuration. For the iodo form, Zr(3)2, other configurations 
were observed. Complexation of 3H2 under the same conditions 
as Zr(1/2)2 (hexane, 70 °C, 24 hrs) afforded the trans 
relationship in solution as the major product; though no crystals 
were acquired the 1H/13C{1H} spectra were directly comparable 
to that of Zr(1/2)2 (See ESI, Figure SI16). A minor product (~20%) 
was also formed under these conditions and this is likely to be 
another unsymmetrical structural isomer similar to the cis form. 
When the complexation was carried out in CH2Cl2, the isolated 
product was still the trans isomer for Zr(1/2)2; with 3H2, 
however, the cis form was observed in the solid state and in 
solution (Scheme 3.).  
 
.
Scheme 1: Preparation of 1-3H2 salans, 4-6H half salalen and 7-9H2 salalen ligands used in this study. 
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Scheme 2: Zr, Hf and Ti(IV) complexes of 1-3H2 
These bonding motifs observed in the solid state structures are 
also corroborated in solution by 1H NMR spectroscopic analysis; 
Zr(trans-1-3)2 has four discrete aromatic resonances indicating 
the respective phenolate groups of both ligands are chemically 
identical. However, for Zr(cis-3)2 there are 8 such resonances 
which is in line with the solid state structure whereby each 
phenolate group sits trans to a different group.  
Hafnium complexes of 1-3H2 were also prepared and similar to 
the Zr(IV) complexes, the bis ligand octahedral complexes were 
preferentially formed with a fac-fac arrangement being 
observed. The iodo form, Hf(3)2 was again observed to adopt 
more coordination isomers relative to Hf(1/2)2. In this case, 
both the cis and trans arrangements were formed in hexane and 
separated through sequential recrystallisations. The cis form 
was supported by X-ray crystallography and the trans form was 
comparable to Hf(1/2)2 by 1H/13C{1H} NMR spectroscopy. 
Hf(trans-3)2 was isolated with a small amount (~12%)  of 
another unsymmetrical isomer in an analogous fashion to 
Zr(trans-3)2 and Hf(cis-3)2 contained Hf(trans-3)2 (~20%) and 
this second unsymmetrical isomer (~10%). DOSY NMR 
spectroscopy was carried out on Hf(cis-3)2 revealing a similar 
diffusion rate for the trans and cis form (See ESI, Figure SI23). 
Scheme 3: Octahedral isomers observed for M(1-3)2 (M= Zr/Hf) 
Addition of Ti(IV) to the chloro ligand, 1H2, afforded the mono 
ligand-isopropoxide complex with five coordination around the 
smaller metal centre.   
Complexation of the salan and salalen ligands to aluminium 
gives rise to two distinct coordination geometries (Scheme 4, 
Figure 2); Al(1-3)Me exhibit a tetrahedral Al(III) centre as the 
piperidine nitrogen is too far removed from the metal to bind. 
Conversely, the position of the imine backbone allows for 
interaction of the nitrogen with the metal centre in Al(7-9)Me 
giving rise to a trigonal bipyramidal arrangement as indicated 
by the angles N(1)-Al(1)-O(2) and O(1)-Al(1)-N(2) of 167.7(2)° 
and 120.6(2)° respectively. Al(7)Me was found to be in a 
monoclinic P21/n space group whereas Al(1)Me and Al(8)Me 
were found to be triclinic P-1. 
 
 
 
Table 1: Selected bond lengths (Å) and angles (°) for group 4 complexes Zr/Hf(1-3)2 
 Zr(1)2 Zr(22) Zr(cis-3)2 Hf(1)2 Hf(cis-3)2 
M-OArx 2.026(3) 2.026(3) 2.026(4) 2.024(2) 2.037(3) 
M-OArtBu 1.976(4) 1.972(3) 1.960(4) 1.988(2) 1.956(3) 
M-N 2.467(4) 2.469(4) 2.445(4) 2.455(2) 2.435(3) 
Arx -ArtBu 4.08/4.06 4.08 4.07/3.81 4.23 /3.99 4.00/3.83 
ArtBuO-M-OArtBu 91.62(13) 92.78(14) 104.25(16) 89.47(7) 103.94(11) 
ArxO-M-OArx 137.54(14) 137.51(14) 107.46(15) 137.84(8) 104.19(10) 
ArxO-M- OArtBu 108.76(14) 108.54(14) 144.93(16) 107.69(8) 147.98(11) 
ArxO-M- OArtBu 109.25(14) 108.72(14) 94.50(15) 108.52(8) 96.35(11) 
ArxO -M-N 77.05(14) 77.19(14) 171.43(15) 77.55(7) 175.12(10) 
ArxO -M-N’ 77.18(14) 76.99(14) 78.77(15) 76.73(7) 77.58(10) 
ArtBuO -M-N 168.60(14) 169.87(15) 173.33(15) 168.39(7) 173.17(10) 
ArtBuO -M-N’ 168.88(14) 170.00(14) 79.30(15) 166.81(8) 80.00(10) 
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Figure 1: The solid state structures of Zr(trans-1)2 (left) and Zr(cis-3)2 (right). Ellipsoids are shown at the 30 % probability level, hydrogen atoms removed for clarity  
 
Solution state NMR investigation of Al(7-9)Me revealed two 
distinct aluminium methyl species in solution for each complex; 
DOSY NMR of Al(7)Me indicated that these two species have 
analogous diffusion coefficients (5.69 × 10-10 m2 s-1) and VT-NMR 
(298K-353K, d8-tol) of Al(7)Me suggested there was no 
interchange between species (see ESI, Figure SI33), this was 
similar for Al(8)Me. Crude NMR spectra of the complexation 
showed that these two species are formed in almost equal 
quantities during the course of the reaction. Purification with 
hexane (recrystallisation or washing) allowed for selective 
isolation or enrichment of one form over the other based on 
their solubility (Figure 3). Elemental analysis of these complexes 
conforms to the expected formula. 
It is suggested, therefore, that these two species are 
diastereoisomeric forms as a consequence of the inherent 
stereochemistry in the ligand backbone and the new chiral 
centre formed on complexation of the amine nitrogen to the 
aluminium centre. For polymerisations, these complexes were 
used as a mixture of these different species rather than isolated 
diastereomers. 
 
Figure 3: 1H NMR of Al(7)Me (d8-tol) showing two isomers (*,+) at differing 
compositions. The green spectra shows the * isomer to be the major form and the 
blue spectra has the + isomer as the main form. For the red spectra, both forms 
exist in equal quantities. 
 
The monophenolate imine ligands 4-6H were successfully 
complexed to aluminium to give well defined trigonal 
bipyramidal structures as demonstrated by a combination of 
NMR spectroscopy and X-ray crystallography. Complexation of 
the amine nitrogen is confirmed by the observation of sharp, 
discrete resonances for the piperidine CH2 groups indicating the 
“locking” of this ring in solution.  
 
Scheme 4: Al(III) complexes of 1-3H2, 4-6H and 7-9H2 
 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5  
Please do not adjust margins 
Please do not adjust margins 
 
Figure 2: The solid state of Al(1)Me (top), Al(4)Me2 (middle) and Al(7)Me (bottom) 
Ellipsoids are shown at the 30 % probability level, hydrogen atoms removed for 
clarity 
Polymerisation 
The catalytic activity of these initiators was demonstrated in the 
ring opening polymerisation (ROP) of rac-LA. In most cases, 
recrystallised monomer was used to make the study more 
comparable to industrially relevant conditions. As the Zr(IV) and 
Hf(IV) complexes had no suitable initiating group, benzyl alcohol 
was added as the co-initiator. This requirement was 
demonstrated by a polymerisation without alcohol for Zr(1)2 in 
which there was only trace amount of polymer formed. This 
approach was also taken for the aluminium methyl complexes 
to generate the active alkoxide in situ. 
For the halo-zirconium complexes, Zr(1-3)2, PLA of reasonable 
molecular weights and narrow molecular weight distributions 
were synthesized after 24 hours (Table 2, entries 1, 4,6-7). All 
initiators demonstrated moderate heterotactic bias, being most 
pronounced for the Zr(1/2)2 complexes (Pr = 0.76). Interestingly, 
the iodo-complex, Zr(trans-3)2, had reduced stereocontrol and 
this could be related to the shift in geometry that was observed 
in the solid and solution state. 
 
Table 2: Polymerisation data for rac-lactide with Group 4 initiators. 
Entry Initiator 
Time 
/h 
Conv. 
%f Prh Mni PDIi 
1 Zr(1)2a 24 93 0.76 16050 1.05 
2 Zr(1)2b 16 89 0.76 8850 1.05 
3 Zr(1)2c 3 96 0.42 29900 1.06 
4 Zr(1)2a,d 24 94 0.76 14400 1.07 
5 Zr(1)2a,e 8 29 - 2000 1.06 
6 Zr(2)2a 24 81 0.76 14900 1.04 
7 Zr(cis-3)2a 24 95 0.66 15400 1.11 
8 Hf(1)2a 24 55 0.76 13350 1.04 
9 Hf(1)2a,d 24 72 0.74 11750 1.04 
10 Hf(2)2a 24 35 0.74 6500 1.04 
11 Hf(trans-3)2 a 24 31 0.69 6850 1.05 
12 Hf(cis-3)2 a 24 28 0.67 7100 1.04 
13 Hf(cis-3)2 a 48 55 0.70 10200 1.04 
14 Ti(1)(OiPr)2f 0.5 67 0.50 20800 1.04 
a Conditions: [LA]:[I]:[BnOH]=100:1:1, 80 °C, toluene b Conditions: 
[LA]:[I]:[BnOH]=100:1:2, 80 °C, toluene. c Conditions: [LA]:[I]:[BnOH]=300:1:1, 130 
°C, solvent free d Sublimed rac-LA. e L-LA. f Conditions: [LA]:[I]=300:1, 130 °C, solvent 
free. g Determined via 1H NMR spectroscopy. h Pr is the probability of heterotactic 
enchainment, determined via homonuclear decoupled 1H NMR spectroscopy. i 
Determined from GPC (in THF) referenced against polystyrene standards. 
Further investigation into the solution polymerisation of Zr(1)2 
demonstrated the controlled character of the reaction with a 
linear increase of polymer molecular weight with conversion 
(Figure 4). Furthermore, the reaction also follows first order 
kinetics as shown by the linear relationship of ln([LA]0/[LA]t) 
against time (Tol, 80 °C, [LA]0 = 0.694 moldm-3, kapp = 0.11 hr-1, 
see ESI Figure SI39). Similar kinetic experiments were carried 
out using Zr(2)2, which revealed similar trends in the 
polymerisation as for Zr(1)2 (See ESI, Figure SI40-41). The 
apparent rate constant for polymerisation was lower (kapp = 
0.069 hr-1). 
Analysis by MALDI-ToF mass spectrometry of polymer obtained 
via Zr(1)2 confirms the benzyl alcohol end group as well as 
revealing evidence of transesterification with the main series 
having a separation of 72 g mol-1 (See ESI Figure SI51), although 
the narrow dispersity is indicative of a well-controlled 
polymerisation.  
To show further the heterotactic nature of the polymerisation 
with Zr(1)2, an experiment was performed with L-LA (Table 2, 
Entry 5). As expected for a heterotactic initiator, the conversion 
is lower with the single enantiomer due to the preference to 
insert alternating L- and D- monomers (cf. an 8 hr 
polymerisation with rac-LA achieved 69 % conversion, Figure 4). 
A melt polymerisation was also carried out for Zr(1)2, with BnOH, 
demonstrating good conversion and relatively higher molecular 
weights after 3 hours (Table 2, entry 3). The stereocontrol of 
this initiator under these conditions is switched to give very 
slight isotacticity.  
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Figure 4: Mn and Mw/Mn against conversion for solution polymerisation of Zr(1)2. 
Linear regression gave the equation of the line at y = 166 – 417 (R2 = 0.96) 
 
For these series of initiators, it is proposed that the ROP 
proceeds via an activated monomer mechanism;13 coordination 
of the lactide carbonyl to the M(IV) centre facilitates attack from 
the free benzyl alcohol to give a zwitterionic intermediate which 
collapses into a dilactyl unit, (see ESI Figure SI56). This is not 
necessarily the case for the bulk polymerisation where yellow 
discolouration was observed. This could be an indication of 
increased ligand dissociation and a shift to a classical 
coordination-insertion mechanism, hence a different 
stereochemistry observed in the isolated PLA. 
The polymerisations performed with the hafnium initiators, 
Hf(1-3)2, generally showed poorer conversion compared to the 
analogous zirconium complexes (Table 2, entries 8, 10-13). 
Selectivity was, however, found to be almost identical with 
good control over molecular weight being maintained. These 
observations of reduced conversion were supported by kinetic 
data for Hf(1)2; a plot of molecular weight against conversion 
shows slight deviation from linearity and the first order plot 
reveals a much reduced rate (kapp = 0.031 hr-1, see ESI Figure 
SI42-43). Performing the same polymerisation with increased 
purity of lactide, i.e. sublimed, showed an increase in 
conversion with Hf(1)2 suggesting this initiator is more 
susceptible to impurities in the monomer (Table 2, entries 8 vs 
9) than Zr(1)2 (Table 2, entries 1 vs 4) which maintained its high 
conversion and narrow dispersity. 
Melt polymerisation of Ti(1)(OiPr)2 at 130 °C showed relatively 
high conversion in a shorter time frame with good control over 
molecular weight however, there was no stereochemical 
preference exhibited by this initiator (Table 2, entry 14). 
The polymerisation of rac-LA with the bicyclic complexes Al(1-
3)Me revealed similar activity and control as the corresponding 
zirconium complexes with the absence of major stereochemical 
preference (Table 3, entries 1-3).  
 
 
 
Table 3:  Polymerisation data for rac-LA with Aluminium based initiators 
Entry Initiator 
Time 
/h 
Conv. 
%a Prb Mnc PDIc 
1 Al(1)Me 24 72 0.51 15900 1.04 
2 Al(2)Me 24 72 0.54 17700 1.04 
3 Al(3)Me 24 85 0.56 21850 1.05 
4 Al(4)Me2 24 91 0.69 15300 1.07 
5 Al(5)Me2 24 96 0.68 20100 1.27 
6 Al(6)Me2 24 72 0.39 14550 1.05 
7 Al(7)Me 240 88 0.37 22700 1.06 
8 Al(8)Me 120 42 0.62 8000 1.07 
9 Al(8)Me 240 88 0.56 20500 1.08 
10 Al(9)Me 240 89 0.68 19350 1.05 
Conditions: [LA]:[I]:[BnOH]=100:1:1, 80 °C, toluene a  Determined via 1H NMR 
spectroscopy. b Pr is the probability of heterotactic enchainment, determined via 
homonuclear decoupled 1H NMR spectroscopy. c Determined from GPC (in THF) 
referenced against polystyrene standards. 
The half salalen complexes, Al(4/5)Me2 showed an increased 
tendency to give heterotactic PLA with a Pr value of 0.69/0.68 
with good conversion after 24 hours but the ortho-methyl 
complex had less control as evidenced by an increased PDI of 
1.27. This is contrasted by the adamantyl half salalen complex 
Al(6)Me2 which saw a switch to slight isotacticity (Pr = 0.39) with 
a reduced activity. These observations are undoubtedly related 
to the steric contribution at the ortho aryl position; the ortho 
methyl group of Al(5)Me2 contributes less steric control over 
the metal centre whereas the bulkier adamantly group hinders 
the polymerisation but gives more control. 
Representative kinetic data for this initiator series was recorded 
for the Al(4)Me2 complex (See ESI, Figure SI44-45). A good 
correlation was observed between molecular weight and 
conversion and further information on initiator activity is 
provided by the apparent rate constant (kapp = 0.096 hr-1).  
The full salalen form of the tBu ligand, Al(7)Me, also imparted 
some stereocontrol over the polymerisation (Table 3, entry 7). 
Isotactic preference was observed (Pr = 0.37) however the 
conversion was comparatively lower than the other initiators 
utilised in this study. For the ortho methyl and adamantly imino 
complexes, Al(8-9)Me, a similar reduced conversion is 
observed; stereochemically these complexes tend towards 
heterotactic PLA with the adamantyl complex yielding the 
greatest enchainment (Pr = 0.68). 
The contrasting activity of these initiators compared to the 
previous entries is likely due to steric crowding of the aluminium 
centre. Unlike the halo complexes, Al(1-3)Me, which have lower 
tetrahedral Al coordination, Al(7-9)Me have a trigonal 
bipyramidal aluminium centre and generally bulkier groups in 
the ortho aryl position. The variation of stereocontrol for these 
initiators is also interesting; introduction of the second 
phenolate generally causes a switch in stereoselective bias and 
the tBu and Ad groups always demonstrate the opposite 
stereocontrol (Table 3, entries 4/7 vs 6/10). 
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Analysis, by MALDI, of PLA derived from Al(2/7)Me and 
Al(4)Me2 shows the expected benzyl alcohol end group (See ESI 
Figures SI52-54). Both the tert-butyl phenolate complexes, 
Al(4)Me2 and Al(7)Me indicate a degree of transesterification 
having a minor series with a separation of 72 g mol-1. These 
observations are likely related to the reduction in steric bulk 
around the metal and the extended reaction time for the mono- 
and bisphenolate respectively. Minimal transesterification is 
evidenced for the halo bicyclic complex Al(2)Me, with the main 
series having a peak separation of 144 g mol-1. 
It is noted that there is a similarity of the bicyclic ligand motif 
seen for 1-3H2 with the organocatalyst DBU. As DBU is known 
to be active for the ROP of rac-LA,14 a brief study was carried 
out to ensure the activity observed is solely due to the metal 
initiator and there is no contribution due to ligand. 
Polymerisation with 1H2 and 7H2 in the melt (130 °C, 
[LA]:[I]:[BnOH]=100:1:1) afforded reasonable conversion after 
24 hours with slight isotacticity (Pr = 0.4), however the polymers 
are brown in color. In both cases, the molecular weight, Mn, was 
around 10,000 Da, by GPC, with a relatively broad molecular 
weight distribution (Mw/Mn ~1.35). Analysis of the MALDI of this 
PLA showed a major series with a 144 g mol-1 separation (see 
ESI Figure SI55), the broad molecular weight in this case is most 
likely to arise from a slower rate of initiation compared to 
propagation. The solution polymerisation (toluene, 80 °C, 
[LA]:[I]:[BnOH]=100:1:1) of 1H2 did not produce polymer after 
24 hours. Therefore it is highly unlikely that the activity of our 
metal complexes is related to ligand disassociation and can be 
assumed to arise from the metal complex.  
Conclusions 
A range of ligands have been prepared based on 2-
(aminomethyl)piperidine and coordinated to a range of metals. 
From similar starting materials, two distinct ligand classes were 
realized offering diverse coordination chemistry when applied 
to zirconium, hafnium, titanium and aluminium; the bicyclic 
ligand form, 1-3H2, preferentially formed octahedral complexes 
M(1-3)2 with hafnium and zirconium and tetrahedral 
mononuclear species were realised with aluminium. 
Monophenolate, 4-6H, and bisphenolate, 7-9H2, imine based 
ligands yielded 5-coordinate aluminium complexes. 
These complexes were tested for the ROP of rac-LA with good 
molecular weight control demonstrated by all initiators. The 
Zr(IV) and Hf(IV) initiators showed a heterotactic bias (Pr = 0.66-
0.76) whereas Ti(1)(OiPr)2 produced atactic PLA. The aluminium 
imino complexes Al(4-9)Mex (x=1,2) gave a greater range of 
tacticities with Al(4-5)Me2 and Al(9)Me yielding heterotactic 
PLA (Pr = 0.68-0.69); Al(6)Me2 and Al(7)Me preferentially 
formed PLA with a slight isotactic bias (Pr = 0.38-0.39). We are 
further investigating other bis-ligated complexes for the 
controlled ROP of lactide and other cyclic esters.  
 
 
 
Experimental 
Materials and methods 
General Experimental. The preparation and characterisation of 
all metal complexes was carried out under inert argon 
atmosphere using standard Schlenk or glovebox techniques. All 
chemicals used were purchased from Aldrich and used as 
received except for rac-LA which was recrystallised from dry 
toluene and Ti(OiPr)4 which was vacuum distilled before use. 
3,5-di-tert-butyl-2-hydroxybenzylbromide, 3,5-
dimethylsalicylaldehyde and 3-(1-adamantyl)-5-
methylsalicylaldehyde were prepared via literature methods.15 
Dry solvents used in handling metal complexes were obtained 
via SPS (solvent purification system). 1H and 13C{1H} NMR 
spectra were recorded on a Bruker 400 or 500 MHz instrument 
and referenced to residual solvent peaks. CDCl3 was dried over 
CaH2 prior to use with metal complexes. Coupling constants are 
given in Hertz. CHN microanalysis was performed by Mr. 
Stephen Boyer of London Metropolitan University. MALDI ToF 
mass spectra were determined on a Bruker Autoflex speed 
instrument using DCTB (trans-2-[3-(4-tert-Butylphenyl)-2-
methyl-2-propenylidene]malononitrile) as the matrix and 
ionized using NaOAc. 
Crystallography. All data were collected on a SuperNova, EOS 
detector diffractometer using radiation CuKα (λ= 1.54184 Å) or 
Mo-Kα (λ= 0.71073 Å) or a Nonius kappa diffractometer using 
Mo-Kα (λ= 0.71073 Å) all recorded at 150(2) K. All structures 
were solved by direct methods and refined on all F2 data using 
the SHELXL-2014 suite of programs. All hydrogen atoms were 
included in idealized positions and refined using the riding 
model, all refinement details are given in the .cif file. 
General Polymerisation Procedure. Polymerisations were 
carried out in a Young’s ampoule under inert argon conditions. 
For a typical solution based polymerisations, rac-lactide (1.0 g, 
0.69 mmol) was dissolved in toluene (10 ml) with required 
amount of initiator ([M]:[I] 100:1); When required, a benzyl 
alcohol co-initiator (typically [I]:[BnOH] 1:1, 7.2 µl) was added. 
The ampoule was then placed in an oil bath (80 °C) for the set 
time. After polymerisation, solvent was removed in vacuo and a 
crude 1H NMR recorded. The polymer was then purified by 
washing with methanol to remove initiator and unreacted 
monomer. For solvent free polymerisations, a higher initiator 
ratio was employed (300:1) and the reaction performed at 
130 °C. After polymerisation, the product was dissolved in 
CH2Cl2 which was then removed in vacuo and a crude 1H NMR 
recorded. The polymer was then purified in the same fashion as 
for solution polymerisations. 
All purified polymers were characterised by a combination of 
gel permeation chromatography (GPC) and homonuclear 
decoupled 1H NMR spectroscopy. GPC was carried out at 1 ml 
min-1 at 35 °C with a THF eluent and referenced against 
polystyrene standards (RI). Tacticity was determined via 1H 
NMR spectroscopy (CDCl3) analysis of the homonuclear 
decoupled methine region utilizing the relationships 
demonstrated by Coates et al.5b 
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Ligand synthesis 
Synthesis of 3,5-dihalosalicylaldehyde/2-
(aminomethyl)piperidine based salans (1-3H2). 2-
(Aminomethyl)piperidine (1 ml, 8.24 mmol) was added 
dropwise to a solution of 3,5-dihalosalicylaldehyde (8.24 mmol) 
in methanol (50 ml). After stirring for 30 minutes, solvent was 
removed and the resultant yellow/orange solid washed with 
cold methanol to yield precursor ligand. Two products observed 
at a ratio of 2:1 (1H NMR). Without further purification, the 
precursor ligand (5.23 mmol) was dissolved in THF (50 ml) and 
3,5-di-tert-butyl-2-hydroxybenzylbromide (1.55 g, 5.23 mmol) 
was added. Triethylamine (2eq, 1 ml, 10.4 mmol) was added 
dropwise and the solution heated to reflux (70 °C) and stirred 
for 3 hours. The suspension was removed via filtration and the 
resultant supernatant reduced in vacuo to afford an orange oil 
from which a colored solid was precipitated from methanol. 
1H2: 
Isolated as a pale yellow powder (2.23 g, 4.41 mmol, 84 %). 1H 
NMR (CDCl3, 400 MHz) δ= 11.83 (s, 1H; ArOH), 9.40 (s, 1H; 
ArOH), 7.22 (d, J = 2.5 Hz, 1H; ArH), 7.18 (d, J=2.5 Hz, 1H; ArH), 
6.78 (d, J = 2.5 Hz, 1H; ArH), 6.45 (d, J = 2.5 Hz, 1H; ArH), 4.00 (s, 
1H; ArCHN2), 3.93 (d, J = 13.0 Hz, 1H; ArCH2), 3.87 (d, J = 13.0 
Hz, 1H; ArCH2), 3.08 (dd, J = 10.5, 6.5 Hz, 1H; CH2), 3.00 (t, J = 
10.0 Hz, 1H; CH2), 2.89 (br d, J = 11.0 Hz, 1H; CH2), 2.61 (m, 1H; 
CH), 2.15 (dt, J = 11.5, 3.0 Hz, 1H; CH2), 1.93 (m, 2H; CH2), 1.76 
(m, 1H; CH2), 1.64 (m, 1H; CH2), 1.37 (m, 2H CH2), 1.44 (s, 9H; 
C(CH3)3), 1.29 (s, 9H; C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 
153.7, 152.4, 140.7, 135.7, 130.2, 129.0, 123.4, 123.1, 122.7, 
122.7,121.7, 120.7, (Ar), 87.9 (ArCHN2), 61.2 (NCH(CH2)2), 58.5, 
57.2, 48.7 (CH2), 34.7, 34.1 (C(CH3)3), 31.6, 29.5 (C(CH3)3), 28.6, 
24.7, 23.3 (CH2). ESI-MS (MeOH): Calcd m/z 
[C28H39N2O2Cl2]+=505.2366, found m/z = 505.2389. 
2H2: 
 Isolated as a yellow powder (2.02 g, 3.39 mmol, 65 %). 1H NMR 
(CDCl3, 400 MHz) δ= 12.00 (s, 1H; ArOH), 9.40 (s, 1H; ArOH), 7.49 
(d, J = 2.5 Hz, 1H; ArH), 7.18 (d, J = 2.5 Hz, 1H; ArH), 6.75 (d, J = 
2.5 Hz, 1H; ArH), 6.58 (d, J = 2.5 Hz, 1H; ArH), 3.97 (s, 1H; 
ArCHN2), 3.91 (d, J = 13.5 Hz, 1H; ArCH2), 3.86 (d, J = 13.5 Hz, 1H; 
ArCH2), 3.08 (dd, J = 10.5 Hz, 6.5 Hz, 1H; CH2), 2.99 (t, J = 10.5 
Hz, 1H; CH2), 2.88 (br d, J = 10.5 Hz, 1H; CH2), 2.61 (m, 1H; CH), 
2.15 (dt, J = 12.0, 3.0 Hz, 1H; CH2), 1.92 (m, 2H; CH2), 1.76 (m, 
1H; CH2), 1.63 (m, 1H; CH2), 1.37 (m, 2H; CH2), 1.29 (s, 9H; 
C(CH3)3), 1.28 (s, 9H; C(CH3)3). 13C NMR (CDCl3, 100 MHz) δ= 
153.8, 153.7, 140.7, 135.7, 135.6, 132.5, 123.6, 123.1, 122.7, 
120.7, 111.3, 110.4 (Ar), 87.8 (ArCHN2), 61.2 (NCH(CH2)2), 58.6, 
57.3, 48.7 (CH2), 34.8, 34.1 (C(CH3)3), 31.7, 28.6 (C(CH3)3), 28.6, 
24.7, 23.4 (CH2). ESI-MS (MeOH): Calcd m/z[C28H39N2O2Br2]+ 
=593.1378, found m/z = 593.1391. 
3H2: 
Isolated as a yellow powder (2.56 g, 3.71 mmol, 71%). 1H NMR 
(CDCl3, 400MHz) δ= 12.17 (s, 1H; ArOH), 9.45 (s, 1H; ArOH), 7.85 
(d, J = 2.0 Hz, 1H; ArH), 7.19 (d, J = 2.5 Hz, 1H; ArH), 6.75 (d, J = 
2.0 Hz, 1H; ArH), 6.73 (d, J = 2.5 Hz, 1H; ArH), 3.90 (s, 1H; 
ArCHN2), 3.89 (d, J = 13.0 Hz, 1H; ArCH2), 3.85 (d, J = 13.0 Hz, 1H; 
ArCH2), 3.08 (dd, J = 10.0, 7.0 Hz, 1H; CH2), 2.99 (t, J = 10.5 Hz, 
1H; CH2), 2.88 (br d, J = 11.0 Hz, 1H; CH2), 2.61 (m, 1H; CH), 2.14 
(dt, J = 3.0, 12.0 Hz, 1H; CH2), 1.92 (m, 2H; CH2), 1.76 (m, 1H; 
CH2), 1.63 (m, 1H; CH2), 1.37 (m, 2H CH2), 1.29 (s, 9H; C(CH3)3), 
1.28 (s, 9H; C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 156.9, 
153.7, 146.7, 140.6, 139.4, 135.6, 123.6, 122.8, 122.7, 120.7, 
86.4, 80.7 (Ar), 87.6 (ArCHN2), 61.1 (NCH(CH2)2), 58.6, 57.3, 48.7 
(CH2), 34.8, 34.1 (C(CH3)3), 31.7, 29.5 (C(CH3)3), 28.6, 24.7, 23.4 
(CH2). ESI-MS(MeOH): Calcd m/z [C28H39N2O2I2]+ =689.1101, 
found m/z = 689.1082. 
Synthesis of 3,5-dialkylsalicylaldehyde/2-aminopiperidine 
based half salalens (4-6H). 2-(Aminomethyl)piperidine (1.0 ml, 
8.24 mmol) was added dropwise to a solution of 3,5-
dialkylsalicylaldehyde (8.24 mmol) in methanol (50 ml). After 
stirring for 1 hour, solvent was removed to afford an orange oil. 
Two products were observed with a ratio dependent on aryl 
substituents (1H NMR). Note: For aluminium complexations, the 
condensation was carried out in a Schlenk tube on a 2 mmol 
scale and was used directly after drying in vacuo. Reaction of 3-
(1-adamantyl)-5-methyl-2-salicylaldehyde was performed on 
2.7 mmol scale. 
4H: 
 Isolated as an orange oil (99% unpurified yield, 9:1 imine:cyclic 
product). Major product (Imine): 1H NMR (CDCl3, 400 MHz) δ= 
13.63 (s, 1H; ArOH), 8.36 (s, 1H; ArCHN), 7.37 (d, J = 2.4 Hz, 1H; 
ArH), 7.07 (d, J = 2.5 Hz, 1H; ArH), 3.68 (ddd, J = 12.0, 4.5, 1.5 
Hz, 1H; NCH2CH), 3.39 (dd, J = 12.0, 8.0 Hz, 1H; NCH2CH), 3.09 
(m, 1H CH2), 2.84 (m, 1H; CH), 2.65 (m, 1H; CH2), 1.83 (m, 1H; 
CH2), 1.74 (m, 1H; CH2) 1.63 (m, 1H; CH2), 1.44 (s, 9H; C(CH3)3), 
1.34 (m, 2H; CH2), 1.29 (s, 9H; C(CH3)3), 1.23 (m, 1H; CH2). 13C{1H} 
NMR (CDCl3, 100 MHz) δ= 167.3 (ArCHN), 157.9, 140.1, 136.6, 
126.9, 125.9, 117.7 (Ar), 66.2 (CH2), 56.6 (NCH(CH2)2), 46.8 
(CH2), 35.0, 34.0 (C(CH3)3), 31.4 (C(CH3)3), 30.7 (CH2), 29.4 
(C(CH3)3), 26.2, 24.5 (CH2). Minor product (Cyclic): 1H NMR 
(CDCl3, 400 MHz) δ= 11.60 (s, 1H; ArOH), 7.24 (d, J = 2.5 Hz, 1H; 
ArH), 6.93 (d, J = 2.5 Hz, 1H; ArH), 4.16 (s, 1H; ArCHN2), 3.21(dd, 
J = 9.5, 7.0 Hz, 1H; NCH2CH), 2.96 (m, 2H; CH2), 2.84 (m, 1H; CH2), 
2.43 (m, 1H; CH), 2.06 (m, 2H; CH2), 1.95 (m, 2H; CH2), 1.87 (m, 
1H; CH2), 1.40 (s, 9H; C(CH3)3), 1.26 (s, 9H; C(CH3)3). 13C{1H} NMR 
(CDCl3, 100 MHz) δ= 153.9, 140.3, 136.1, 124.9, 124.0, 120.5 
(Ar), 84.0 (ArCHN2), 63.5 (NCH(CH2)2), 50.5, 48.4 (CH2), 35.0, 
34.0 (C(CH3)3), 31.6, 29.5 (C(CH3)3), 29.0, 24.8, 23.8 (CH2). ESI-
MS(MeOH): Calcd m/z [C21H34N2ONa]+ = 353.2569, found m/z = 
353.2551 
5H: 
 Isolated as an orange oil (98 % unpurified yield, 3:1 imine:cyclic 
product). Major product (Imine): 1H NMR (CDCl3, 400 MHz) δ= 
13.26 (s, 1H; ArOH), 8.24 (s, 1H; ArCHN) 6.97 (s, 1H; ArH), 6.83 
(s, 1H; ArH), 3.61 (ddd, J = 12.0, 4.5, 1.5 Hz, 1H; NCH2CH), 3.36 
(ddd, J = 12.0, 8.0, 1.0 Hz, 1H; NCH2CH), 3.01 (br d, J = 12.0 Hz, 
1H; CH), 2.79 (m, 1H; CH2), 2.59 (d t, J = 12.0, 3.0 Hz, 1H; CH2), 
2.22 (s, 6H; 2CH3), 1.79 (m, 1H; CH2), 1.68 (m, 1H; CH2), 1.58 
(m, 1H; CH2), 1.37 (m, 2H; CH2), 1.19 (m, 1H; CH2). 13C{1H} NMR 
(CDCl3, 100 MHz) δ= 166.4 (ArCHN), 157.0, 134.4, 129.0, 127.2, 
125.6, 117.6 (Ar), 66.1 (CH2), 56.7 (NCH(CH2)2), 46.8, 30.7, 26.2, 
24.5 (CH2), 20.3, 15.4 (CH3) Minor product (Cyclic): 1H NMR 
(CDCl3, 400 MHz) δ= 11.44 (s, 1H; ArOH), 6.85 (s, 1H; ArH), 6.68 
(s, 1H; ArH), 4.09 (s, 1H; ArCHN2), 3.14 (dd, J = 9.0, 6.5 Hz, 1H; 
CH2), 2.88 (m, 2H; CH2), 2.18 (s, 3H; CH3), 2.16 (s, 3H; CH3), 2.00 
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(dd, J = 12.0, 3.0 Hz, 1H; CH2), 1.90 (m, 1H; CH2), 1.79 (m, 1H; 
CH2), 1.68 (m, 1H; CH2), 1.58 (m, 1H; CH2), 1.37 (m, 2H; CH2). 
13C{1H} NMR (CDCl3, 100 MHz) δ= 131.7, 128.1 (Ar), 83.1 
(ArCHN2), 63.6 (NCH(CH2)2), 50.4, 48.5, 29.1, 25.0, 23.8 (CH2), 
20.3, 15.6 (CH3). ESI-MS (MeOH): Calcd m/z [C15H23N2O2]+ 
=247.1810, found m/z = 247.1807. 
6H: 
 Isolated as a yellow powder (0.92 g, 2.5 mmol, 93 %, 9:1 
imine:cyclic product). Major product (Imine): 1H NMR (CDCl3, 
400 MHz) δ= 13.60 (s, 1H; ArOH), 8.33 (s, 1H; ArCHN), 7.08 (d, J 
= 2.0 Hz, 1H; ArH), 6.90 (d, J = 1.5 Hz, 1H; ArH), 3.70 (dd, J = 12.0, 
4.5 Hz, 1H; CH2), 3.42 (m, 1H; CH2), 3.08 (br d, J = 11.5 Hz, 1H; 
CH), 2.90 (m, 1H; CH2), 2.67 (td, J = 12.0, 3.0 Hz, 1H; CH2), 2.28 
(s, 3H; CH3), 2.24 (t, J = 3.4 Hz, 1H; CH2), 2.18 (br s, 6H; CH2 Ad), 
2.09 (br s, 4H; CH2/CH ad), 1.83 (m, 1H; CH2), 1.78 (br s, 8H; 
CH2/CH2 ad), 1.68 (m, 1H; CH2). 13C{1H} NMR (CDCl3, 100 MHz) δ= 
167.3 (ArCHN), 158.3, 137.4, 130.6, 129.5, 126.8, 118.3 (Ar), 
66.0 (CH2), 56.6 (NCH(CH2)2), 46.7 (CH2), 40.3, 37.1 (CH2 Ad), 36.9 
(C ad), 30.5 (CH2), 29.1 (CH ad), 25.9, 24.4 (CH2), 20.7 (CH3). ESI-
MS (MeOH): Calcd m/z [C24H34N2O1Na]+= 389.2569, found m/z 
= 389.2572. 
Synthesis of 3,5-dialkylsalicylaldehyde/2-aminopiperidine 
based full salalens (7-9H2). Without purification, the isolated 
half salalen (4-6H) was dissolved in THF (50ml) and 3,5-di-tert-
butyl-2-hydroxybenzylbromide (2.45 g, 8.24 mmol) was added. 
Triethylamine (2eq, 2.3 ml, 16.4 mmol) was added dropwise and 
the solution heated to reflux (70 °C) and stirred for 3 hours. The 
suspension was filtered and the resultant supernatant reduced 
in vacuo to afford an orange oil from which the product was 
isolated via recrystallisation from methanol. Note: Reaction of 
3-(1-adamantyl)-5-methyl-2-salicyladehyde adduct was carried 
out on 2 mmol scale. 
7H2: 
Isolated as a yellow powder (2.85 g, 5.18 mmol, 63%). 1H NMR 
(CDCl3, 400 MHz) δ= 13.51 (s, 1H; ArOH), 11.10 (s, 1H; ArOH), 
8.29 (s, 1H; ArCHN), 7.39 (d, J = 2.5 Hz, 1H; ArH), 7.20 (d, J = 2.5 
Hz, 1H; ArH), 7.04 (d, J = 2.5 Hz, 1H; ArH), 6.86 (d, J = 2.5 Hz, 1H; 
ArH), 4.27 (br s, 1H; NCH(CH2)2), 3.97 (dd, J = 12.5, 3.5 Hz, 1H; 
NCH2), 3.74 (dd, J = 12.5, 7.0 Hz, 1H; NCH2), 3.56 (m, 1H; CH2), 
2.87 (m, 1H; CH), 2.78 (m, 1H; CH2), 2.33 (br s, 1H; CH2), 1.72 (br 
m, 6H; CH2), 1.46 (s, 9H; C(CH3)3), 1.37 (s, 9H; C(CH3)3), 1.31 (s, 
9H; C(CH3)3), 1.29 (s, 9H; C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) 
δ= 167.3 (ArCHN), 157.9, 154.4, 140.3, 140.0, 136.6, 135.5, 
127.0, 126.0, 123.1, 122.6, 121.1, 117.8 (Ar), 58.5 (CH2), 56.7 
(NCH(CH2)2), 35.0, 34.8, 34.11, 34.09 (C(CH3)3), 31.7, 31.5, 29.5, 
29.4 (C(CH3)3), 20.0 (CH2). ESI-MS (MeOH): Calcd m/z 
[C36H56N2O2 Na]+ = 571.4240, found m/z  = 571.4230. 
8H2: 
 Isolated as a yellow powder (2.62 g, 5.67 mmol, 69%). 1H NMR 
(CDCl3, 400 MHz) δ= 13.19 (s, 1H; ArOH), 11.07 (br s, 1H; ArOH), 
8.23 (s, 1H; ArCHN), 7.19 (d, J = 2.5 Hz, 1H; ArH), 7.01 (s, 1H; 
ArH), 6.86 (d, J = 2.5 Hz, 1H; ArH), 6.84 (d, J = 2.5 Hz, 1H; ArH), 
4.26 (br s, 1H; NCH(CH2)2), 3.99 (dd, J = 12.5, 4.0 Hz, 1H; ArCH2), 
3.71 (dd, J = 12.2, 7.2 Hz, 1H; ArCH2), 3.56 (br s, 1H; CH2), 2.86 
(m, 2H; CH2), 2.25 (s, 6H; 2CH3), 2.22 (m, 1H; CH2), 1.84 (m, 1H; 
CH2), 1.62 (m, 5H; CH2), 1.37 (s, 9H; C(CH3)3), 1.28 (s, 9H; 
C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 166.4 (ArCHN), 
156.9, 154.4, 140.4, 135.5, 134.3, 129.0, 127.1, 125.6, 123.1, 
122.7, 121.1, 117.7 (Ar), 58.5 (CH2), 56.7 (NCH(CH2)2), 34.8, 34.1 
(C(CH3)3), 31.7, 29.5 (C(CH3)3), 25.0 (CH2), 20.3, 15.4 (CH3). ESI-
MS (MeOH): Calcd m/z [C30H44N2O2 Na]+ = 487.3301, found m/z 
= 487.3332. 
 
9H2: 
 Isolated as a yellow powder (1.02 g, 1.74 mmol, 87 %). 1H NMR 
(CDCl3, 400 MHz) δ= 13.45 (s, 1H; ArOH), 11.15 (br s, 1H; ArOH), 
8.24 (s, 1H; ArCHN), 7.20 (d, J = 2.2 Hz, 1H; ArH), 7.07 (d, J = 2.0 
Hz, 1H; ArH), 6.86 (d, J = 1.5 Hz, 1H; ArH), 6.84 (d, J = 2.5 Hz, 1H; 
ArH), 4.26 (br s, 1H; NCH(CH2)2), 3.98 (br d, J = 13.0 Hz, 1H; 
ArCH2), 3.69 (dd, J = 13.0, 7.5 Hz, 1H; ArCH2), 2.93 (m, 2H; CH2), 
2.28 (s, 3H; CH3), 2.18 (br s, 7H; CH2 Ad), 2.08 (br s, 4H; CH2/CH 
ad), 1.80 (m, 10H; CH2/CH2 ad), 1.64 (m, 2H; CH2), 1.39 (s, 9H; 
C(CH3)3), 1.29 (s, 9H; C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 
167.1 (ArCHN), 158.2, 154.4, 140.3, 137.4, 135.5, 130.5, 129.5, 
126.7, 123.2, 122.6, 121.1, 118.3 (Ar), 58.5 (CH2), 56.7 
(NCH(CH2)2), 40.2, 37.1 (CH2 ad), 34.8, 34.1 (C(CH3)3), 31.7 (CH ad), 
29.5, 29.1 (C(CH3)3), 25.0 (CH2), 20.6 (CH3). ESI-MS (MeOH): 
Calcd m/z [C30H45N2O2]+ = 585.4420, found m/z  = 585.4562. 
 
Complex synthesis 
Synthesis of Zirconium complexes Zr(trans-1-3)2. 
Zr(OiPr)4OHiPr (0.388 g, 1 mmol) was dissolved in hexane (10 ml) 
and ligand 1-3H2 (2 mmol) was added. The solution was heated 
to reflux (70 °C) for 24 hours before purification by filtration or 
crystallization. 
Zr(1)2: 
Product precipitated from solution during complexation and 
collected via filtration as a white powder (0.857 g, 0.78 mmol, 
78 %). Crystals isolated from hexane/CH2Cl2 mixture. 1H NMR 
(CDCl3, 400 MHz), δ= 7.11 (d, J = 2.5 Hz, 2H; ArH), 7.08 (d, J = 2.5 
Hz, 2H; ArH), 7.04 (d, J = 2.5 Hz, 2H; ArH), 6.06 (d, J = 2.5 Hz, 1H; 
ArH), 5.19 (d, J = 12.0 Hz, 2H; ArCH2N), 3.83 (t, J = 11.5 Hz, 2H; 
CH2), 3.60( d, J = 12.0 Hz,  2H; ArCH2N), 3.56 (s, 2H; ArCHN2) 3.12 
(dd, J = 12.0 ,5.0 Hz, 2H; CH2), 2.48 (br d, J = 10.5 Hz, 2H; CH), 
2.37 (m, 2H; CH2), 1.82 (m, 4H; CH2), 1.74 (m, 2H; CH2), 1.62 (m, 
2H; CH2), 1.53 (m, 3H; CH2), 1.35 (s, 18H; C(CH3)3), 1.29 (m, 3H; 
CH2), 1.18 (s, 18H; C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 
157.0, 153.1, 141.6, 136.0, 129.1, 128.4, 125.6, 124.6, 124.6, 
124.2, 124.2, 121.5 (Ar), 92.3 (ArCHN2), 62.9, 61.9 (CH2), 60.1 
(NCH(CH2)2), 49.5 (CH2), 34.9, 34.2 (C(CH3)3), 31.8, 30.1 
(C(CH3)3), 27.3, 24.5, 23.4 (CH2). Elemental analysis 
(C56H72Cl4N4O4Zr1) Calcd in %: C, 61.24; H, 6.61; N, 5.10. Found: 
C, 61.16; H, 6.70; N, 5.13. 
Zr(2)2: 
 Product precipitated from solution during complexation and 
collected via filtration as a white powder (1.06 g, 0.82 mmol, 82 
%). Crystals isolated from hexane. 1H NMR (CDCl3, 400 MHz), δ= 
7.39 (d, J = 2.5 Hz, 2H; ArH), 7.09 (d, J = 2.5 Hz, 2H; ArH), 7.03 (d, 
J = 2.5 Hz, 2H; ArH), 6.22 (d, J = 2.5 Hz, 1H; ArH), 5.27 (d, J = 12.0 
Hz, 2H; ArCH2N), 3.80 (t, J = 11.5 Hz, 2H; CH2), 3.60 (d, J = 12.0 
Hz, 2H; ArCH2N), 3.54 (s, 2H; ArCHN2) 3.11 (dd, J = 12.0, 5.0 Hz, 
2H; CH2), 2.46 (br d, J = 10.5 Hz, 2H; CH), 2.36 (m, 2H; CH2), 1.81 
(m, 4H; CH2), 1.72 (m, 2H; CH2), 1.62 (m, 2H; CH2), 1.51 (m, 3H; 
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CH2), 1.36 (s, 18H; C(CH3)3), 1.30 (m, 3H; CH2), 1.17 (s, 18H; 
C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 157.0, 154.4, 141.6, 
136.0, 134.5, 131.9, 126.0, 124.6, 124.3, 124.1, 115.4, 108.7 
(Ar), 93.2 (ArCHN2), 63.0, 62.0 (CH2), 60.9 (NCH(CH2)2), 49.5 
(CH2), 34.9, 34.2 (C(CH3)3), 31.9, 30.3 (C(CH3)3)), 27.3, 24.5, 23.4 
(CH2). Elemental analysis (C56H72Br4N4O4Zr1) Calcd in %: C, 
52.71; H, 5.69; N, 4.39. Found: C, 52.64; H, 5.56; N, 4.51. 
Zr(trans-3)2:  
Product precipitated from solution during complexation and 
collected via filtration as a white powder (0.96 g, 0.66 mmol, 
66%). 1H NMR (CDCl3, 400 MHz), δ= 7.75 (d, J = 2.0 Hz, 2H; ArH), 
7.10 (d, J = 2.5 Hz, 2H; ArH), 7.02 (d, J = 2.5 Hz, 2H; ArH), 6.39 (d, 
J = 2.0 Hz, 2H; ArH), 5.47 (d, J = 12.0 Hz, 2H; ArCH2N), 3.75 (t, J = 
12.0 Hz,  2H; CH2), 3.57 (d, J = 12.0 Hz, 2H; ArCH2N), 3.47 (s, 2H; 
ArCHN2), 3.08 (dd, J = 12.0, 5.0 Hz; 2H; CH2), 2.40 (br d, J = 10.5, 
2H; CH), 2.34 (m, 2H; CH2), 1.80 (m, 4H; CH2), 1.69 (m, 3H; CH2), 
1.58 (m, 3H; CH2), 1.51 (m, 4H; CH2), 1.37 (s, 18H; C(CH3)3), 1.18 
(s, 18H; C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 157.5, 157.0, 
145.6, 141.5, 138.9, 136.0, 125.6, 124.7, 124.3, 124.0, 93.1 (Ar), 
92.4 (ArCHN2), 78.6 (Ar), 63.4, 62.0 (CH2), 60.9 (NCH(CH2)2), 49.5 
(CH2), 35.0, 34.3 (C(CH3)3), 32.0, 30.5 (C(CH3)3), 27.2, 24.5, 23.4 
(CH2). Elemental analysis (C56H72I4N4O4Zr1) Calcd in %: C, 45.94; 
H, 4.96; N, 3.83. Found: C, 45.99; H, 5.07; N, 3.71. 
Zr(cis-3)2: 
Zr(OiPr)4OHiPr (0.388 g, 1 mmol) was dissolved in CH2Cl2 (10 ml) 
and ligand 3H2 (1.38g, 2 mmol) was added. After 3 hours, 
solvent was removed in vacuo and product recrystallised from 
hot hexane mixture as colourless crystals (0.144 g, 0.10 mmol, 
10 %). 1H NMR (CDCl3, 400 MHz) δ= 7.74 (d, J = 2.0 Hz, 1H; ArH), 
7.66 (d, J = 2.0 Hz, 1H; ArH), 7.60 (d, J = 2.0 Hz, 1H; ArH), 7.14 (d, 
J = 2.0 Hz, 1H; ArH), 7.06 (d, J = 2.0 Hz, 1H; ArH), 6.98 (d, J = 2.0 
Hz, 1H; ArH), 6.54 (d, J = 2.0 Hz, 1H; ArH), 6.15 (d, J = 2.0 Hz, 1H; 
ArH), 5.47 (s, 1H; ArCHN2), 5.21 (d, J = 12.0 Hz, 1H; ArCH2N), 4.90 
(dd, J = 9.5, 8.0 Hz, 1H; CH2 ), 4.02 (d, J = 14.0 Hz, 1H; ArCH2N), 
3.78 (t, J = 11.5 Hz, 1H; CH2), 3.65 (dd, J = 12.0, 6.0 Hz, 2H; CH2 
), 3.59 (s, 1H; ArCHN2), 3.33 (br d, J = 10.5 Hz, 1H; CH2), 3.15 (dd, 
J = 12.0, 6.0 Hz, 1H; CH2 ), 2.70 (br q, J = 8.0 Hz, 1H; CH), 2.41 (m, 
3H; CH/CH2), 2.27 (m, 1H; CH2), 1.85 (m, 8H; CH2), 1.63 (m, 1H; 
CH2), 1.46 (s, 9H; C(CH3)3), 1.37 (s, 9H; C(CH3)3), 1.31 (m, 4H; 
CH2), 1.23 (s, 9H; C(CH3)3), 1.21 (s, 9H; C(CH3)3). 13C{1H} NMR 
(CDCl3, 100 MHz) δ= 161.2, 158.0, 156.0, 155.9, 146.2, 145.8, 
141.8, 140.2, 138.9, 136.3, 135.4, 135.0, 125.7, 125.3, 124.7, 
124.1, 124.0, 123.8, 123.7, 122.8, 92.7 (Ar), 92.6 (ArCHN2), 87.8 
(Ar), 82.1 (ArCHN2), 80.8, 78.3 (Ar), 63.9 (NCH(CH2)2), 63.3, 63.2, 
63.1, 61.2 (CH2), 60.7 (NCH(CH2)2), 50.5, 48.7 (CH2), 34.8, 34.7, 
34.3, 34.0 (C(CH3)3), 32.0, 31.6, 30.3, 30.2 (C(CH3)3), 29.7, 28.0, 
25.0, 24.7, 24.2, 23.5 (CH2). Elemental analysis (C56H72I4N4O4Zr1) 
Calcd in %: C, 45.94; H, 4.96; N, 3.83. Found: C, 45.85; H, 5.01; 
N, 3.84. 
Synthesis of Hafnium complexes Hf(1-3)2: 
 Hf(OiPr)4OHiPr (0.415 g, 1 mmol) was dissolved in hexane (10 
ml) and ligand 1-3H2 (2 mmol) was added. The solution was 
heated to reflux (70°C) for 24 hours before purification by 
recrystallisation. 
Hf(1)2: 
Recrystallised from hexane/CH2Cl2/toluene mixture as 
colourless crystals. (0.875 g, 0.738 mmol, 74 %). 1H NMR (CDCl3, 
400 MHz), δ= 7.12 (d, J = 2.5 Hz, 2H; ArH), 7.11 (d, J = 2.5 Hz, 2H; 
ArH), 7.02 (d, J = 2.5 Hz, 2H; ArH), 6.05 (d, J = 2.5 Hz, 2H; ArH), 
5.26 (d, J = 12.0 Hz, 2H; ArCH2N), 3.84 (t, J = 12.0 Hz, 2H; CH2), 
3.64 (s, 2H; ArCHN2), 3.59 (d, J = 12.0 Hz, 2H; ArCH2N), 3.13 (dd, 
J = 12.5, 5.0 Hz, 2H; CH2), 2.49 (br d, J = 10.5 Hz, 2H; CH), 2.37 
(m, 2H; CH2), 1.83 (m, 4H; CH2), 1.74 (m, 2H; CH2), 1.63 (m, 2H; 
CH2), 1.54 (m, 3H; CH2), 1.35(s, 18H; C(CH3)3), 1.31 (m, 3H; CH2), 
1.19 (s, 18H; C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 157.2, 
153.2, 141.3, 136.6, 129.0, 128.2, 125.5, 125.2, 124.5, 124.2, 
123.9, 121.5 (Ar), 92.4 (ArCHN2), 63.1, 62.1 (CH2) 60.9 
(NCH(CH2)2), 49.5 (CH2), 34.8, 34.1 (C(CH3)3), 31.8, 30.1 
(C(CH3)3), 27.2, 24.5, 23.3 (CH2). Elemental analysis 
(C56H72Cl4N4O4Hf1) Calcd in %: C, 56.74; H, 6.12; N, 4.73. Found: 
C, 56.59; H, 6.27; N, 4.62. Note: CH2Cl2 present in the crystal unit 
cell and 1H NMR spectra. 
Hf(2)2:  
Recrystallised from hexane/CH2Cl2 mixture as colourless 
crystals. (0.481 g, 0.353 mmol, 35 %). 1H NMR (CDCl3, 400 MHz), 
δ= 7.42 (d, J = 2.5 Hz, 2H; ArH), 7.12 (d, J = 2.5 Hz, 2H; ArH), 7.03 
(d, J = 2.5 Hz, 2H; ArH), 6.22 (d, J = 2.5 Hz, 2H; ArH), 5.34 (d, J = 
12.0 Hz, 2H; ArCH2N), 3.82 (t, J = 11.5 Hz,  2H; CH2), 3.62 (s, 2H; 
ArCHN2), 3.58 (d, J = 12.0 Hz, 2H; ArCH2N), 3.13 (dd, J = 12.0, 4.5 
Hz; 2H; CH2), 2.46 (br d, J = 10.0 Hz, 2H; CH), 2.37 (m, 2H; CH2), 
1.83 (m, 4H; CH2), 1.72 (m, 2H; CH2), 1.63 (m, 2H; CH2), 1.54 (m, 
3H; CH2), 1.36(s, 18H; C(CH3)3), 1.31 (m, 3H; CH2), 1.19 (s, 18H; 
C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 157.3, 154.6, 141.3, 
136.7, 134.5, 131.8, 125.9, 124.5, 124.2, 124.0, 116.0, 108.7 
(Ar), 92.4 (ArCHN2), 63.2, 62.1 (CH2), 60.9 (NCH(CH2)2), 49.5 
(CH2), 34.9, 34.2 (C(CH3)3), 31.9, 30.2 (C(CH3)3), 27.2, 24.5, 23.4 
(CH2). Elemental analysis (C56H72Br4N4O4Hf1) Calcd in %: C, 
49.34; H, 5.32; N, 4.11. Found: C, 49.59; H, 5.49; N, 4.09. Note: 
CH2Cl2 present in the crystal unit cell and 1H NMR spectra. 
Hf(trans-3)2: 
 First recrystallisation from hexane/CH2Cl2 mixture yield isomer 
as colourless crystals. (0.293g, 0.189 mmol, 19 %). 1H NMR 
(CDCl3, 400 MHz), δ= 7.77 (d, J = 2.0 Hz, 2H; ArH), 7.11 (d, J = 2.5 
Hz, 2H; ArH), 7.02 (d, J=2.5 Hz, 2H; ArH), 6.39 (d, J = 2.0 Hz, 2H; 
ArH), 5.53 (d, J = 12.0 Hz, 2H; ArCH2N), 3.78 (t, J = 11.5 Hz, 2H; 
CH2), 3.58 (m, 4H; ArCHN2/ArCH2N), 3.10 (dd, J = 12.5, 5.0 Hz; 
2H; CH2), 2.46 (br d, J = 10.5 Hz, 2H; CH), 2.34 (m, 3H; CH2), 1.81 
(m, 5H; CH2), 1.70 (m, 2H; CH2), 1.61 (m, 2H; CH2), 1.52 (m, 2H; 
CH2), 1.37 (s, 18H; C(CH3)3), 1.31 (m, 2H; CH2), 1.18 (s, 18H; 
C(CH3)3). 13C{1H} NMR (CDCl3, 100 MHz) δ= 157.6, 157.2, 145.6, 
141.2, 138.8, 136.6, 125.5, 124.5, 124.1, 124.0, 93.6, 78.6 (Ar), 
92.5 (ArCHN2), 63.5, 62.2 (CH2), 60.8 (NCH(CH2)2), 49.5 (CH2), 
34.9, 34.2 (C(CH3)3), 32.2, 30.4 (C(CH3)3), 27.1, 24.5, 23.3 (CH2). 
Elemental analysis (C56H72I4N4O4Hf1) Calcd in %: C, 43.36; H, 
4.68; N, 3.61. Found: C, 43.24; H, 4.74; N, 3.55. 
Hf(cis-3)2: 
 Second recrystallisation from hexane/CH2Cl2 mixture as 
colourless crystals (0.429 g, 0.277 mmol, 28 %). 1H NMR (CDCl3, 
400 MHz) δ= 7.75 (d, J = 2.0 Hz, 1H; ArH), 7.66 (d, J = 2.0 Hz, 1H; 
ArH), 7.58 (d, J = 2.0 Hz, 1H; ArH), 7.15 (d, J = 2.5 Hz, 1H; ArH), 
7.07 (d, J = 2.5 Hz, 1H; ArH), 6.97 (d, J = 2.5 Hz, 1H; ArH), 6.53 (d, 
J = 2.0 Hz, 1H; ArH), 6.15 (d, J = 2.5 Hz, 1H; ArH), 5.50 (s, 1H; 
ArCHN2), 5.28 (d, J = 12.0 Hz, 1H; ArCH2N), 4.96 (dd, J = 10.0, 8.0 
Hz, 1H; CH2 ), 4.07 (d, J = 14.0 Hz, 1H; ArCH2N), 3.76 (m, 2H; CH2), 
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3.67 (s, 1H; ArCHN2), 3.64 (d, J = 12.5 Hz, 1H; CH2 ), 3.34 (br d, J 
= 11.0 Hz, 1H; CH2), 3.16 (dd, J = 12.0, 6.0 Hz, 1H; CH2 ), 2.70 (br 
q, J = 8.0 Hz, 1H; CH), 2.40 (m, 3H; CH/CH2), 2.28 (m, 1H; CH2), 
1.92 (br d, J = 12.0 Hz, 1H; CH2), 1.82 (m, 7H; CH2), 1.63 (m, 2H; 
CH2), 1.45 (s, 9H; C(CH3)3), 1.37 (s, 9H; C(CH3)3), 1.22 (s, 9H; 
C(CH3)3), 1.21 (s, 9H; C(CH3)3), 1.19 (m, 3H; CH2). 13C{1H} NMR 
(CDCl3, 100 MHz) δ= 161.7, 158.1, 156.4, 155.9, 146.2, 145.8, 
141.4, 140.1, 138.8, 136.8, 136.1, 134.9, 125.5, 125.3, 124.7, 
124.1, 124.0, 123.7, 123.4, 122.6, 93.2 (Ar), 92.7 (ArCHN2), 88.5 
(Ar), 82.0 (ArCHN2), 80.6, 78.4 (Ar), 63.9 (NCH(CH2)2), 63.5, 63.4, 
63.3, 61.4 (CH2), 60.6 (NCH(CH2)2), 50.6, 48.7 (CH2), 34.8, 34.7, 
34.2, 33.9 (C(CH3)3), 32.1, 31.6, 30.2, 30.18 (C(CH3)3). 29.7, 28.0, 
25.0, 24.7, 24.2, 23.5 (CH2). Elemental analysis (C56H72I4N4O4Hf1) 
Calcd in %: C, 43.36; H, 4.68; N, 3.61. Found: C, 43.24; H, 4.75; 
N, 3.62. 
Synthesis of Titanium complex Ti(1)(OiPr)2:  
Ti(OiPr)4 (0.30 ml, 1 mmol) was added to ligand, 1H2 (0.504 g, 1 
mmol) in toluene (10ml). After 1 hour, solvent was removed in 
vacuo and complex recrystallised from hexane to yield yellow 
crystals (0.353g, 0.523 mmol, 53%). 1H NMR (CDCl3, 400 MHz), 
δ=7.31 (d, J = 2.4 Hz, 1H; ArH), 7.21 (d, J = 2.4 Hz, 1H; ArH), 7.17 
(d, J = 2.4 Hz, 1H; ArH), 6.85 (d, J = 2.3 Hz, 1H; ArH), 5.09 (2sept, 
J = 6.1 Hz, 2H; (CH3)2CH ), 4.66 (s, 1H; ArCHN2), 3.43 (dd, J = 10.1 
Hz, 7.0 Hz, 1H; CH2), 3.37 (br d, J = 10.4, 1H; CH2), 3.26 (d, J = 
12.7 Hz, 1H; ArCH2N), 3.14 (d, J = 12.7 Hz, 1H; ArCH2N), 2.39 (t, 
J = 10.6 Hz, 1H; CH2), 2.30 (br q, J = 9.8 Hz, 1H; CH2), 1.91 (m, 2H; 
CH2), 1.78 (m, 3H; CH2), 1.47 (s, 9H; C(CH3)3), 1.45 (d, J= 4.6 Hz, 
3H; (CH3)2CH), 1.44 (d, J = 4.8 Hz, 3H; (CH3)2CH), 1.37 (m, 2H; 
CH2), 1.25 (m (s, 2xd), 15H; C(CH3)3/(CH3)2CH). 13C{1H} NMR 
(CDCl3, 100 MHz,) δ= 158.8, 158.5, 141.7, 135.4, 128.9, 126.7, 
125.0, 124.6, 124.5, 123.1, 123.0, 121.8 (Ar), 81.8, 80.8, 79.7 
(CH), 65.3 (CH2) 57.2 (CH), 55.5, 51.5 (CH2), 34.9, 34.2 (C(CH3)3), 
31.6, 29.7 (C(CH3)3), 29.2 (CH2), 26.3, 26.1, 25.94, 25.91 (CH3), 
24.7, 24.4 (CH2). Elemental analysis (C34H50Cl2N2O4Ti1) Calcd in 
%: C, 60.99; H, 7.53; N, 4.18. Found: C, 60.88; H, 7.68; N, 4.26. 
Synthesis of bisphenolate Aluminium complexes, Al(1-3)Me: 
AlMe3 (2M, 0.5 ml, 1 mmol) was added dropwise to a solution 
of 1-3H2 (1 mmol) in toluene (10 ml) at 40 °C. After complete 
addition, the solution was then heated to 80 °C and 
complexation allowed for 3 hours. Solvent was then removed in 
vacuo and the product recrystallised from hexane. 
Al(1)Me:  
Isolated as colorless crystals (0.160 g, 0.29 mmol, 29 %). 1H NMR 
(d8-tol, 400MHz), δ= 7.48 (d, J = 2.5 Hz, 1H; ArH), 7.31 (d, J = 2.5 
Hz, 1H; ArH), 6.73 (d, J = 2.5 Hz, 1H; ArH), 6.58 (d, J = 2.5 Hz, 1H; 
ArH), 3.40 (d, J = 12.5 Hz, 1H; NCH2Ar), 2.97 (s, 1H; ArCHN2), 2.71 
(d, J = 12.5 Hz, 1H; NCH2Ar), 2.55 (dd, J = 11.0, 8.0 Hz, 1H; 
NCH2CH), 2.19 (br d, J = 10.5 Hz, 1H; NCH2CH’), 2.05 (dd, J = 11.0, 
9.5 Hz, 1H; CH2), 1.60 (s, 9H; C(CH3)3), 1.41 (s, 9H; C(CH3)3), 1.29 
(m, 3H; CH2), 1.04 (m, 5H; CH2), -0.39 (s, 3H; AlMe). 13C{1H} NMR 
(d8-tol, 100MHz) δ= 155.9, 154.2, 139.7, 138.8, 131.7, 129.8, 
126.8, 125.1, 123.9, 121.5, 121.0, 120.6, (Ar), 90.8 (ArCHN2), 
61.3 (NCH(CH2)2), 57.1, 55.4, 48.3 (CH2) 35.4, 34.3 (C(CH3)3), 
32.0, 30.1 (C(CH3)3), 28.0, 24.4, 24.1 (CH2), -12.4 (AlMe). 
Elemental analysis (C29H39Cl2N2O2Al1) Cald in %: C, 63.85; H, 
7.21; N, 5.14. Found: C, 63.77; H, 7.31; N, 5.07. Note: ArH 13C 
resonance obscured by d8-toluene. 
Al(2)Me: 
 Isolated as colorless crystals (0.362 g, 0.57 mmol, 57%). 1H NMR 
(d8-tol, 400 MHz), δ= 7.66 (d, J = 2.5 Hz, 1H; ArH), 7.48 (d, J = 2.5 
Hz, 1H; ArH), 6.76 (d, J = 2.5 Hz, 1H; ArH), 6.73 (d, J = 2.5 Hz, 1H; 
ArH), 3.38 (d, J = 12.5 Hz, 1H; NCH2Ar), 2.94 (s, 1H; ArCHN2), 2.67 
(d, J = 12.5 Hz, 1H; NCH2Ar), 2.55 (dd, J = 11.0, 8.0 Hz, 1H; 
NCH2CH’), 2.18 (br d, J = 10.0 Hz, 1H; NCH2CH’), 2.04 (dd, J = 
11.0, 9.5 Hz, 1H; CH2), 1.60 (s, 9H; C(CH3)3), 1.42 (s, 9H; C(CH3)3), 
1.28 (m, 3H; CH2), 1.04 (m, 4H; CH2), 0.81 (m, 1H; CH2), -0.38 (s, 
3H; AlMe). 13C{1H} NMR (d8-tol, 100 MHz) δ= 156.0, 155.5, 
139.7, 138.8, 137.3, 133.4, 125.1, 123.9, 120.99, 120.95, 117.3, 
108.6, (Ar), 90.8 (ArCHN2), 61.3 (NCH(CH2)2), 57.1, 55.4, 48.3 
(CH2), 35.4, 34.3 (C(CH3)3), 32.1, 30.1 (C(CH3)3), 28.0, 24.4, 24.1 
(CH2), -12.4 (AlMe). Note: ArH 13C resonance obscured by d8-
toluene. Elemental analysis (C29H39Br2N2O2Al1) Cald in %: C, 
54.90; H, 6.20; N, 4.42. Found: C, 54.78; H, 6.33; N, 4.33.  
Al(3)Me: 
 Isolated as colorless crystals (0.517 g, 0.71 mmol, 71%). 1H NMR 
(d8-tol, 400 MHz), δ=8.11 (d, J = 2.0 Hz, 1H; ArH), 7.50 (d, J = 2.2 
Hz, 1H; ArH), 6.97 (d, J = 2.0 Hz, 1H; ArH), 6.73 (d, J = 2.5 Hz, 1H; 
ArH), 3.34 (d, J = 12.5 Hz, 1H; NCH2Ar), 2.87 (s, 1H; ArCHN2), 2.59 
(d, J = 13.0 Hz, 1H; NCH2Ar), 2.51 (dd, J = 11.0, 8.0 Hz, 1H; 
NCH2CH’), 2.16 (br d, J = 10.5 Hz, 1H; NCH2CH’), 2.02 (dd, J = 
11.0, 9.5 Hz, 1H; CH2), 1.61 (s, 9H; C(CH3)3), 1.42 (s, 9H; C(CH3)3), 
1.25 (m, 3H; CH2), 1.05 (m, 4H; CH2), 0.78 (m, 1H; CH2), -0.38 (s, 
3H; AlMe). 13C{1H} NMR (d8-tol, 100 MHz) δ= 158.2, 155.9, 
148.5, 140.4, 139.6, 138.7, 125.1, 123.9, 121.0, 120.3, 94.3 (Ar) 
90.6 (ArCHN2), 78.3 (Ar), 61.2 (NCH(CH2)2), 56.9, 55.2, 48.3 
(CH2), 28.0, 24.3, 24.1 (CH2), 35.4, 34.3 (C(CH3)3), 32.1, 30.1 
(C(CH3)3), -13.1 (AlMe). Note: ArH 13C/1H resonance obscured by 
d8-toluene. Elemental analysis (C29H39I2N2O2Al1) Calcd in %: C, 
47.82; H, 5.40; N, 3.85. Found: C, 47.96; H, 5.37; N, 3.67.  
Synthesis of monophenolate Aluminium complexes, Al(4-
6)Me2: AlMe3 (2M, 1 ml, 2 mmol) was added to a  solution of 4-
6H (2 mmol) in toluene (10 ml). After complete addition, the 
solution was stirred for 1 hour before purification via filtration 
or recrystallisation. 
Al(4)Me2: 
Product precipitated from solution during complexation and 
collected by filtration as a yellow solid (0.557g, 1.44 mmol, 
72%). Crystals isolated from a hot toluene/hexane mixture. 1H 
NMR (400 MHz, d8-tol) δ= 7.64 (d, J = 2.5 Hz, 1H; ArH), 7.41 (s, 
1H;ArCHN), 6.81 (d, J = 2.5 Hz, 1H; ArH), 2.78 (br d, J = 13.5 Hz, 
1H; CH2), 2.48 (m, 2H; CH2), 2.25 (m, 2H; CH/CH2), 1.68 (s, 9H 
C(CH3)3), 1.39 (m, 1H; CH2),1.37 (s, 9H C(CH3)3), 1.21 (br d, J = 
13.0 Hz, 1H; CH2), 1.11 (br dd, J = 13.5, 3.0 Hz, 1H; CH2), 0.98 (t 
q, J = 13.0, 4.0 Hz, 1H; CH2), 0.77 (q t, J = 13.0, 4.0 Hz, 1H; CH2), 
0.55 (d t, J = 12.0, 3.0 Hz, 1H; NH), 0.34 (q d, J = 13.0, 4.0 Hz, 1H; 
CH2) -0.37 (s, 3H; AlMe), -0.50 (s, 3H; AlMe). 13C{1H} NMR (d8-
tol, 100 MHz) δ= 172.0 (ArCHN), 165.8, 141.0, 136.1, 131.1, 
127.7 117.6 (Ar), 62.7 (CH2), 54.4 (NCH(CH2)2), 44.6 (CH2), 35.6, 
34.1 (C(CH3)3), 31.6, 29.7 (C(CH3)3), 26.5, 23.4 (CH2), -6.8, -9.4 
(AlMe). Note: ArH 13C resonance obscured by d8-toluene. 
Elemental analysis (C23H39AlN2O) Calcd in %: C, 71.46; H, 10.17; 
N, 7.25. Found: C, 71.35; H, 10.29; N, 7.24.  
Al(5)Me2: 
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Recrystallised from a toluene/hexane mixture to yield yellow 
crystals (0.177 g, 0.586 mmol, 29%). 1H NMR (400 MHz, d8-tol) 
δ= 7.41 (s, 1H; ArCHN), 6.94 (s, 1H; ArH), 6.50 (s, 1H; ArH), 2.78 
(br d, J = 13.5 Hz, 1H; CH2), 2.63 (dd, J = 13.5, 4.5 Hz, 1H; CH2), 
2.54 (t, J = 12.0, 1H; CH2), 2.31 (s, 3H; CH3), 2.27 (m, 1H; CH), 
2.27 (m, 1H; CH2), 2.15 (s, 3H; CH3), 1.42 (br d, J = 13.0 Hz, 1H; 
CH2), 1.23 (br d, J = 13.0 Hz, 1H; CH2), 1.14 (br dd, J = 13.0, 3.0 
Hz, 1H; CH2), 1.0 (q t, J = 13.0, 4.0 Hz, 1H; CH2), 0.85 (q t, J = 13.0, 
4.0 Hz, 1H; CH2), 0.61 (br d t, J = 10.5, 2.0 Hz, 1H; NH), 0.42 (q d, 
J = 12.5 Hz, 4.0 Hz, 1H; CH2), -0.39 (s, 3H; AlMe), -0.51 (s, 3H; 
AlMe). 13C{1H} NMR (d8-tol, 100 MHz) δ= 171.3 (ArCHN), 164.9, 
138.3, 130.8, 130.6, 123.1, 116.9 (Ar), 63.0 (CH2), 54.5 
(NCH(CH2)2), 44.9, 30.0, 26.6, 23.6 (CH2), 20.3, 16.5 (CH3), -6.3, -
8.6 (AlMe). Elemental analysis (C17H27AlN2O) Calcd in %: C, 
67.52; H, 9.00; N, 9.26. Found: C, 67.48; H, 9.13; N, 9.18. Note: 
Ar-CH3 13C resonance obscured by d8-toluene. 
Al(6)Me2: 
Recrystallised from hot toluene to yield yellow crystals (0.320 g, 
0.74 mmol, 37 %). 1H NMR (400 MHz, d8-tol) δ= 7.40 (s, 1H; 
ArCHN), 7.19 (d, J = 2.5 Hz, 1H; ArH), 6.54 (d, J = 2.0 Hz, 1H; ArH), 
2.80 (br d, J = 14.0 Hz, 1H; CH2), 2.45 (m, 5H; CH2 /CH2 ad), 2.27 
(s, 3H; CH3), 2.21 (m, 2H; CH2/CH), 2.17 (m, 3H; CH ad), 1.97 (br 
d, J = 11.5 Hz, 3H; CH2 ad), 1.83 (br d, J = 12.0 Hz, 3H; CH2 ad), 1.37 
(br d, J = 13.5 Hz, 1H; CH2), 1.20 (br d, J = 13.5 Hz, 1H; CH2), 1.09 
(br d, J = 12.5 Hz, 1H; CH2), 0.97 (q t, J = 13.0, 3.5 Hz, 1H; CH2), 
0.76 (q t, J = 13.0, 3.5 Hz, 1H CH2), 0.56 (d t, J = 12.0, 2.5 Hz, 1H; 
NH), 0.32 (q d, J = 12.5, 3.5, 1H; CH2), -0.37 (s, 3H; AlMe), -0.54 
(s, 3H; AlMe). 13C{1H} NMR (d8-tol, 100 MHz) δ= 171.5 (ArCHN), 
166.0, 141.6, 134.8, 131.2, 122.8, 118.3 (Ar), 62.6 (CH2), 54.5 
(NCH(CH2)2), 44.6 (CH2), 40.61, 37.9 (CH2 Ad), 37.5 (C ad), 29.9 (CH 
ad), 29.8, 26.5, 23.4 (CH2), 20.9 (CH3), -6.2, -9.0 (AlMe). 
Elemental analysis C26H39AlN2O) Calcd in %: C, 73.90; H, 9.30; N, 
6.63. Found: C, 73.73; H, 9.40; N, 6.54. 
Synthesis of bisphenolate Aluminium complexes, Al(7-9)Me: 
AlMe3 (2M, 0.5 ml, 1 mmol) was added dropwise to a solution 
of 7-9H2 (1 mmol) in toluene (10 ml) at 40 °C. After complete 
addition, the solution was then heated to 80 °C and 
complexation allowed for 3 hours. Solvent was then removed in 
vacuo and the product recrystallised from hexane. 
Al(7)Me: 
 Isolated as yellow crystals (0.326 g, 0.55 mmol, 55%). Two main 
series at a ratio of 3:2.  1H NMR (400 MHz, d6-benzene) Major 
Product δ= 7.76 (m, 1H; ArH), 7.57 (d, J = 2.5 Hz, 1H; ArH), 7.49 
(s, 1H; ArCHN), 6.99 (d, J = 2.5 Hz, 1H; ArH), 6.88 (m, 1H; ArH), 
3.83 (d, J = 12.5 Hz, 1H; NCH2Ar), 3.66 (d, J = 13.0 Hz, 1H; 
NCH2Ar), 3.13 (t, J = 13.0 Hz, 1H; CH2), 2.66 (m, 2H; CH/CH2), 
2.28 (m, 2H; CH2), 2.21 (dd, J = 14.0, 5.0 Hz; 1H; CH2), 1.83 (s, 9H 
C(CH3)3), 1.65 (s, 9H C(CH3)3), 1.45 (s, 9H C(CH3)3), 1.36 (s/m, 
10H C(CH3)3/CH2), 0.91 (m, 2H; CH2), 0.69 (br t, J = 13.0 Hz, 1H; 
CH2), 0.58 (br d, J = 13.3 Hz, 1H; CH2), -0.23 (s, 3H; AlMe); 13C{1H} 
NMR (d6-benzene, 100 MHz) δ= 173.0 (ArCHN), 166.0, 157.3, 
141.4, 138.6, 138.3, 137.0, 131.7, 127.3, 124.3, 124.1, 121.7, 
117.8 (Ar), 55.7, 55.2 (CH2), 51.5 (NCH(CH2)2), 46.2 (CH2), 35.8, 
35.6, 34.3, 34.2 (C(CH3)3), 32.3, 31.6, 30.3, 30.1 (C(CH3)3), 23.6, 
20.6, 17.5 (CH2), -8.6 (AlMe). 
Minor Product δ= 7.76 (m, 1H; ArH), 7.63 (d, J = 2.5 Hz, 1H; ArH), 
7.44 (s, 1H;ArCHN), 7.03 (d, J = 2.5 Hz, 1H; ArH), 6.88 (m, 1H; 
ArH), 3.52 (d, J = 12.0 Hz, 1H; NCH2Ar), 3.24 (d, J = 12.0 Hz, 1H; 
NCH2Ar), 2.87 (t, J = 13.0 Hz, 1H; CH2), 2.75 (m, J = 13.5 Hz, 1H; 
CH), 2.28 (m, 1H; CH2), 1.87 (s, 9H C(CH3)3), 1.83 (s, 9H C(CH3)3), 
1.47 (s, 9H C(CH3)3), 1.39 (s, 9H C(CH3)3), 1.36 (m, 2H; CH2), 1.09 
(m, 3H; CH2), 0.91 (m, 2H; CH2), 0.69 (br t, J = 13.0 Hz, 1H; CH2) 
-0.42 (s, 3H; AlMe). 13C{1H} NMR (d6-benzene, 100 MHz) δ= 
173.8 (ArCHN), 166.3, 157.5, 141.5, 138.5, 138.2, 137.0, 131.9, 
127.3, 123.94, 123.90, 121.7, 117.9 (Ar), 57.7 (NCH(CH2)2), 56.7, 
48.9, 44.8 (CH2), 35.9, 35.8, 34.4 (C(CH3)3), 32.3, 31.7, 30.5, 30.3 
(C(CH3)3), 20.5, 18.7, 18.4 (CH2), -11.0 (AlMe). Elemental 
analysis (C37H57AlN2O2) Calcd in %: C, 75.47; H, 9.76; N, 4.76. 
Found: C, 75.33; H, 9.85; N, 4.88. 
Al(8)Me: 
Isolated as yellow crystals (0.241g, 0.477 mmol, 48%). Two 
series with a ratio approximately 1:1.  1H NMR (400 MHz, d6-
benzene) Form 1: δ= 7.55 (s, 1H; ArH), 7.50 (s, 1H; ArCHN), 7.05 
(s, 1H; ArH), 6.98 (s, 1H; ArH), 6.62 (s, 1H; ArH), 3.83 (d, J = 13.0 
Hz, 1H; NCH2Ar), 3.63 (d, J = 13.0 Hz, 1H; NCH2Ar), 3.20 (m, 1H; 
CH2), 2.57 (m, 1H; CH), 2.56 (s, 3H; CH3), 2.54 (s, 3H; CH3), 2.38 
(m, 2H; CH2), 2.04 (dd, J = 4.0 Hz, 1H; CH2), 1.84 (s, 9H C(CH3)3), 
1.61 (s, 9H C(CH3)3), 1.39 (m, 2H; CH2), 1.08 (m, 1H; CH2), 0.89 
(m, 1H; CH2), 0.69 (m, 1H; CH2), 0.53 (br d, J = 14.4 Hz, 1H; CH2), 
-0.19 (s, 3H; AlMe); 13C{1H} NMR (d6-benzene, 100 MHz) δ= 
172.0 (ArCHN), 165.7, 157.3, 139.0, 138.5, 138.2, 131.0, 130.1, 
124.1, 123.8, 123.5, 121.6, 116.7 (Ar), 56.4, 55.3 (CH2), 51.9 
(NCH(CH2)2), 46.2 (CH2), 35.6, 35.3 (C(CH3)3), 30.1, 30.0 
(C(CH3)3), 23.6, 20.4, 18.7 (CH2), 16.6, 16.4 (CH3), -8.1 (AlMe). 
Form 2: δ= 7.59 (s, 1H; ArH), 7.50 (s, 1H;ArCHN), 7.07 (s, 1H; 
ArH), 6.98 (s, 1H; ArH), 6.62 (s, 1H; ArH), 3.27 (d, J = 12.0 Hz, 1H; 
NCH2Ar), 3.18 (d, J = 12.0 Hz, 1H; NCH2Ar), 2.84 (m, 1H; CH), 2.75 
(br d, 1H; CH2) 2.66 (br t, J = 13.5 Hz, 1H; CH2), 2.38 (m, 2H; CH2), 
2.17 (s, 6H; CH3), 1.46 (s, 9H C(CH3)3), 1.44 (s, 9H C(CH3)3), 1.39 
(m, 2H; CH2), 1.08 (m, 1H; CH2), 0.89 (m, 1H; CH2), 0.69 (m, 1H; 
CH2), 0.69 (br t, J = 13.2 Hz, 1H; CH2), -0.31 (s, 3H; AlMe). 13C{1H} 
NMR (d6-benzene, 100 MHz) δ= 172.9 (ArCHN), 165.8, 157.6, 
138.7, 138.3, 137.9, 130.9, 130.3, 124.1, 123.7, 123.5, 121.3, 
116.9 (Ar), 56.9 (NCH(CH2)2), 55.5, 48.6, 45.0 (CH2), 34.36, 34.34 
(C(CH3)3), 32.31, 31.27 (C(CH3)3), 20.7 (CH2), 20.51, 20.47 (CH3), 
18.41 17.4 (CH2), -10.5 (AlMe). Notes: Form 1 resonance at 3.20 
ppm obscured by form 2. CH resonance at 2.57 ppm obscured 
by CH3 resonance. Elemental analysis (C31H45AlN2O2) Calcd in %: 
C, 73.78; H, 8.99; N, 5.55. Found: C, 73.64; H, 9.08; N, 5.45. 
Al(9)Me: 
 Isolated as yellow crystals (0.265 g, 0.424 mmol, 42 %). Two 
series with a ratio of 3:2. 1H NMR (400 MHz, d6-benzene) Major 
Product δ= 7.55 (d, J = 2.5 Hz, 1H; ArH), 7.50 (s, 1H; ArCHN), 7.32 
(m, 1H; ArH), 6.99 (m, 1H; ArH), 6.62 (m, 1H; ArH), 3.96 (d, J = 
13.0 Hz, 1H; NCH2Ar), 3.57 (d, J = 13.0 Hz, 1H; NCH2Ar), 3.15 (m, 
1H; CH2), 2.71 (m, 1H; CH), 2.66 (m, 1H; CH2), 2.60 (m, 6H; CH2 
Ad), 2.32 (m, 4H; CH2/CH Ad), 2.26 (s, 3H; CH3), 2.06 (m, 3H; CH2 
Ad), 1.97 (dd, J = 14.1, 5.3 Hz; 1H; CH2), 1.90 (m, 3H; CH2 Ad), 1.61 
(s, 9H C(CH3)3), 1.44 (s, 9H C(CH3)3), 1.43 (m, 1H; CH2), 1.37 (m, 
1H; CH2), 1.07 (m, 1H; CH2), 0.83 (m, 1H; CH2), 0.68 (br t, J = 14.4 
Hz, 1H; CH2), 0.48 (br d, J = 13.9 Hz, 1H; CH2), -0.23 (s, 3H; AlMe); 
13C{1H} NMR (d6-benzene, 100 MHz) δ= 173.0 (ArCHN), 166.1, 
157.3, 141.8, 138.5, 138.3, 135.5, 130.8, 123.9, 123.8, 123.6, 
121.9, 118.4 (Ar), 55.4, 54.6 (CH2), 50.4 (NCH(CH2)2), 48.7 (CH2), 
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41.0, 37.9 (CH2 ad), 35.5, 34.3 (C(CH3)3), 32.2, 29.8 (C(CH3)3) 29.8 
(CHad), 20.9 (CH3), 20.8, 19.7, 17.5 (CH2), -7.7 (AlMe). 
Minor Product δ= 7.60 (d, J = 2.5 Hz, 1H; ArH), 7.48 (s, 1H; 
ArCHN), 7.32 (m, 1H; ArH), 6.99 (m, 1H; ArH), 6.62 (m, 1H; ArH), 
3.32 (d, J = 12.0 Hz, 1H; NCH2Ar), 3.15 (m, 1H; NCH2Ar), 2.79 (m, 
1H; CH), 2.66 (m, 1H; CH2), 2.60 (m, 6H; CH2 Ad), 2.32 (m, 5H; 
CH2/CH Ad), 2.28 (s, 3H; CH3), 2.06 (m, 3H; CH2 Ad), 1.90 (m, 3H; 
CH2 Ad), 1.83 (s, 9H C(CH3)3), 1.47 (s, 9H C(CH3)3), 1.37 (m, 3H; 
CH2), 1.07 (m, 1H; CH2), 0.90 (m, 1H; CH2), 0.84 (m, 2H; CH2),  -
0.42 (s, 3H; AlMe). 13C{1H} NMR (d6-benzene, 100 MHz) δ= 173.8 
(ArCHN), 166.6, 157.6, 141.8 138.5, 138.2, 136.0, 131.2, 127.3, 
123.94, 123.90, 121.7, 117.9 (Ar), 56.5 (NCH(CH2)2), 55.5, 45.5, 
45.0 (CH2) 41.0, 37.74 (CH2 ad), 37.70 ((C(CH3)3), 35.9, 35.8 
(C(CH3)3), 35.7 (C(CH3)3), 30.1 (CH3), 30.0 (CH ad), 23.6, 18.2, 18.0 
(CH2), -9.7 (AlMe). Elemental analysis (C37H57AlN2O2) Calcd in %: 
C, 75.47; H, 9.76; N, 4.76. Found: C, 75.33; H, 9.85; N, 4.88. 
Notes: ArCH2 and CH2 resonances of minor and major series 
overlap at 3.15 ppm. 
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Lara-Sánchez, A. M. Rodrıǵuez, Organometallics 2014, 33, 1859-
1866. 
 6 (a)  M. D. Jones, L. Brady, P. McKeown, A. Buchard, P. M. 
Schafer, L. H. Thomas, M. F. Mahon, T. J. Woodman, J. P. Lowe, 
Chem. Sci. 2015, 6, 5034-5039. (b)  S. L. Hancock, M. F. Mahon, 
M. D. Jones, Dalton Trans. 2013, 42, 9279-9285. (c)  A. Pilone, K. 
Press, I. Goldberg, M. Kol, M. Mazzeo, M. Lamberti, J. Am. Chem. 
Soc. 2014, 136, 2940-2943. (d)  E. L. Whitelaw, G. Loraine, M. F. 
Mahon, M. D. Jones, Dalton Trans. 2011, 40, 11469-11473. (e) 
 N. Nomura, R. Ishii, Y. Yamamoto, T. Kondo, Chem. Eur. J. 
2007, 13, 4433-4451. (f)  P. Hormnirun, E. L. Marshall, V. C. 
Gibson, A. J. P. White, D. J. Williams, J. Am. Chem. Soc. 2004, 126, 
2688-2689. (g)  Z. Y. Zhong, P. J. Dijkstra, J. Feijen, Angew. 
Chem. Int. Ed. 2002, 41, 4510-4513. (h)  N. Nomura, R. Ishii, M. 
Akakura, K. Aoi, J. Am. Chem. Soc. 2002, 124, 5938-5939. (i)  T. 
M. Ovitt, G. W. Coates, J. Polym. Sci., Part A: Polym. Chem. 2000, 
38, 4686-4692. (j)  M. Wisniewski, A. LeBorgne, N. Spassky, 
Macromol. Chem. Phys. 1997, 198, 1227-1238. 
 7 (a)  D. C. Aluthge, B. O. Patrick, P. Mehrkhodavandi, Chem. 
Commun. 2013, 49, 4295-4297. (b)  D. C. Aluthge, E. X. Yan, J. M. 
Ahn, P. Mehrkhodavandi, Inorg. Chem. 2014. (c)  K. M. Osten, 
D. C. Aluthge, P. Mehrkhodavandi, Dalton Trans. 2015, 44, 6126-
6139. (d)  A. Pietrangelo, M. A. Hillmyer, W. B. Tolman, Chem. 
Commun. 2009, 2736-2737. (e)  I. Yu, A. Acosta-Ramírez, P. 
Mehrkhodavandi, J. Am. Chem. Soc. 2012, 134, 12758-12773. 
 8 (a)  C. A. Wheaton, P. G. Hayes, B. J. Ireland, Dalton Trans. 
2009, 4832-4846. (b)  V. Poirier, T. Roisnel, J.-F. Carpentier, Y. 
Sarazin, Dalton Trans. 2009, 9820-9827. (c)  M. H. Chisholm, J. C. 
Gallucci, K. Phomphrai, Inorg. Chem. 2004, 43, 6717-6725. (d) 
 M. H. Chisholm, J. Gallucci, K. Phomphrai, Chem. Commun. 
2003, 48-49. (e)  K. Devaine-Pressing, J. H. Lehr, M. E. Pratt, L. N. 
Dawe, A. A. Sarjeant, C. M. Kozak, Dalton Trans. 2015, 44, 12365-
12375. 
 9 (a)  C. Bakewell, T.-P.-A. Cao, X. F. Le Goff, N. J. Long, A. 
Auffrant, C. K. Williams, Organometallics 2013, 32, 1475-1483.
 (b)  C. Bakewell, A. J. P. White, N. J. Long, C. K. Williams, 
Angew. Chem. Int. Ed. 2014, 53, 9226-9230. (c)  B. M. 
Chamberlain, Y. Sun, J. R. Hagadorn, E. W. Hemmesch, V. G. 
Young, M. Pink, M. A. Hillmyer, W. B. Tolman, Macromolecules 
1999, 32, 2400-2402. (d)  A. Amgoune, C. M. Thomas, T. Roisnel, 
J.-F. Carpentier, Chem.  Eur. J. 2006, 12, 169-179. (e)  C. 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 14  
Please do not adjust margins 
Please do not adjust margins 
Bakewell, A. J. P. White, N. J. Long, C. K. Williams, Inorg. Chem. 
2015, 54, 2204-2212. (f)  W. Gu, P. Xu, Y. Wang, Y. Yao, D. Yuan, 
Q. Shen, Organometallics 2015, 34, 2907-2916. 
 10 (a)  A. J. Chmura, D. M. Cousins, M. G. Davidson, M. D. 
Jones, M. D. Lunn, M. F. Mahon, Dalton Trans. 2008, 1437-1443.
 (b)  A. J. Chmura, M. G. Davidson, C. J. Frankis, M. D. Jones, M. 
D. Lunn, Chem. Commun. 2008, 1293-1295. (c)  M. D. Jones, S. L. 
Hancock, P. McKeown, P. M. Schafer, A. Buchard, L. H. Thomas, 
M. F. Mahon, J. P. Lowe, Chem. Commun. 2014, 50, 15967-15970.
 (d)  A. Sauer, A. Kapelski, C. Fliedel, S. Dagorne, M. Kol, J. 
Okuda, Dalton Trans. 2013, 42, 9007-9023. (e)  A. Stopper, K. 
Press, J. Okuda, I. Goldberg, M. Kol, Inorg. Chem. 2014, 53, 9140-
9150. (f)  A. J. Chmura, M. G. Davidson, M. D. Jones, M. D. Lunn, 
M. F. Mahon, A. F. Johnson, P. Khunkamchoo, S. L. Roberts, S. S. 
F. Wong, Macromolecules 2006, 39, 7250-7257. (g)  T. R. Forder, 
M. F. Mahon, M. G. Davidson, T. Woodman, M. D. Jones, Dalton 
Trans. 2014, 43, 12095-12099. 
 11 (a)  S. L. Hancock, M. D. Jones, C. J. Langridge, M. F. 
Mahon, New J. Chem. 2012, 36, 1891-1896. (b)  M. Kol, M. 
Shamis, I. Goldberg, Z. Goldschmidt, S. Alfi, E. Hayut-Salant, Inorg. 
Chem. Commun. 2001, 4, 177-179. (c)  Z. Zhong, P. J. Dijkstra, J. 
Feijen, J. Am. Chem. Soc. 2003, 125, 11291-11298. 
 12  H. J. Beim, A. R. Day, J. Heterocycl. Chem. 1970, 7, 355-360. 
 13 (a)  M. Normand, V. Dorcet, E. Kirillov, J.-F. Carpentier, 
Organometallics 2013, 32, 1694-1709. (b)  N. Maudoux, T. 
Roisnel, V. Dorcet, J.-F. Carpentier, Y. Sarazin, Chem. Eur. J. 2014, 
20, 6131-6147. (c)  S.-C. Rosca, D.-A. Rosca, V. Dorcet, C. M. 
Kozak, F. M. Kerton, J.-F. Carpentier, Y. Sarazin, Dalton Trans. 
2013, 42, 9361-9375. 
 14  B. G. G. Lohmeijer, R. C. Pratt, F. Leibfarth, J. W. Logan, D. 
A. Long, A. P. Dove, F. Nederberg, J. Choi, C. Wade, R. M. 
Waymouth, J. L. Hedrick, Macromolecules 2006, 39, 8574-8583. 
 15 (a)  P. D. Knight, P. N. O'Shaughnessy, I. J. Munslow, B. S. 
Kimberley, P. Scott, J. Organomet. Chem. 2003, 683, 103-113.
 (b)  A. I. Kochnev, I. I. Oleynik, I. V. Oleynik, S. S. Ivanchev, G. 
A. Tolstikov, Russ. Chem. Bull. 2007, 56, 1125-1129. (c)  A. 
Sokolowski, J. Müller, T. Weyhermüller, R. Schnepf, P. 
Hildebrandt, K. Hildenbrand, E. Bothe, K. Wieghardt, J. Am. Chem. 
Soc. 1997, 119, 8889-8900. 
 
 
 
 
 
 
 
 
 
 
 
 
